Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2011

The Characterization of PG0228 in Porphyromonas gingivalis W83
Courtney Schlenker
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Physiology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/219

This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has
been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass.
For more information, please contact libcompass@vcu.edu.

THE CHARACTERIZATION OF PG0228 IN PORPHYROMONAS GINGIVALIS W83

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Physiology and Biophysics at Virginia Commonwealth University.

by

COURTNEY DANIELLE SCHLENKER
Bachelor of Science in Biology, University of Toledo, 2007
Director: JANINA P. LEWIS, PH.D.
ASSOCIATE PROFESSOR, PHILIPS INSTITUTE OF OCMB
SCHOOL OF DENTISTRY

Virginia Commonwealth University
Richmond, Virginia
May, 2011

ii

ACKNOWLEDGEMENTS

Most importantly, I would like to thank Dr. Lewis for this exciting project and giving me the
opportunity to work in her lab. Her mentorship and constant support have made pursuing a
Masters degree a challenging yet rewarding process. No matter how busy she was, she always
managed to find the time to address any concerns or questions I might have had. In addition to
Dr. Lewis, I would like to thank the other members of my committee, Dr. Rife and Dr. Qiao, for
their insight and guidance on this project. A special thank you goes to Cecilia Anaya-Bergman
for her mentorship during my research rotation last year. I would especially like to thank Sai
Yanamandra, Dr. Karl Thompson, and Dr. Tiana Wyant for their time, patience, guidance, and
advice this past year and a half. Finally, I must thank the rest of the lab including Kandice
Klepper, Anuya Paranjape, Tyrone King, Evys Collazo, Cheyanne Warren, and Huan Mo for their
support and friendship.
Lastly, I would like to thank my parents and family for giving me the unconditional love,
support, and confidence to go out and chase my dreams. You have been there to guide me
through life’s many roadblocks, and through your example, you have shown me the power of
hard work and dedication.

iii

TABLE OF CONTENTS

ACKNOWLEDGEMENTS ...............................................................................................................ii
LIST OF TABLES .............................................................................................................................v
LIST OF FIGURES ..........................................................................................................................vi
LIST OF ABBREVIATIONS ............................................................................................................viii
ABSTRACT .......................................................................................................................................x
INTRODUCTION .............................................................................................................................1
1.1. Periodontal Disease ................................................................................................1
1.2. Oral Microflora .......................................................................................................4
1.3. Porphyromonas gingivalis ......................................................................................5
1.4. Gene Regulation in Porphyromonas gingivalis ......................................................6
1.5. Regulatory small RNAs (sRNAs) ...........................................................................7
1.6. Sm Family of RNA-Associated Proteins ................................................................9
1.7. Hfq Protein ..............................................................................................................10
1.
MATERIALS AND METHODS .......................................................................................................21
2.1. Project Aims............................................................................................................21
2.2. Bacterial Strains and Plasmids ................................................................................25
2.3. Growth Conditions and Media ................................................................................25
2.4. Generation of P. gingivalis Mutant Strains.............................................................29
2.5. Generation of Δ0228 Mutant Porphyromonas gingivalis Strain ............................29
2.6. Generation of 0228-HaLo Porphyromonas gingivalis Strain .................................35
2.7. Growth Curve of Δ0228 Mutant .............................................................................39
2.8. Microarray Analysis of Δ0228 Mutant ...................................................................39
2.9. Survival of Δ0228 Mutant Strain with Eukaryotic Cells ........................................45
2.10. Immunoprecipitation with 0228-HaLo Tagged Strain ............................................46
2.11. Bioinformatics.........................................................................................................51
RESULTS .........................................................................................................................................52
3.1. Sequence Alignment with PG0228 .........................................................................52
3.2. Generation of Δ0228 Mutant Strain ........................................................................55
3.3. Generation of 0228-HaLo tagged Porphyromonas gingivalis Strain .....................62
3.4. Evaluation of Δ0228 Growth Compared to Wild Type W83 .................................71
3.5. Differential Expression Using Microarray Analysis...............................................74
3.6. Analysis of Δ0228’s Ability to Survive with Host Cells ........................................83
DISCUSSION ...................................................................................................................................88

iv

4.1.
4.2.
4.3.
4.4.
4.5.
4.6.

Δ0228 Strain ...........................................................................................................88
Differential Gene Expression ..................................................................................90
RNA Binding to PG0228 ........................................................................................94
Evaluation of Phenotypic Changes in Δ0228 .........................................................96
Alternate Hypothesis ...............................................................................................98
Future Studies .........................................................................................................99

LITERATURE CITED .....................................................................................................................101
VITA ..................................................................................................................................................109

v

LIST OF TABLES

Table 1: Primer Sequences................................................................................................................28
Table 2: Optical Density of Δ0228 Compared to W83 ....................................................................72
Table 3: Upregulated Genes Detected in Δ0228 Strain ...................................................................76
Table 4: Downregulated Genes Detected in Δ0228 Strain ...............................................................77
Table 5: Transcription Profile of nusA .............................................................................................80
Table 6: Transcription Profile of luxR ..............................................................................................81
Table 7: Transcription Profile of luxS ..............................................................................................82
Table 8: Colonies Found on the Blood Agar Plates after HN4 Invasion .........................................86

vi

LIST OF FIGURES

Figure 1: Periodontal Diseases .........................................................................................................3
Figure 2: Examples of Hfq Regulation in E. coli .............................................................................13
Figure 3: Structure Summary of Hfq from Pseudomonas aeruginosa .............................................16
Fig. 4a:

Presence or Absence of an hfq gene in Completed Genomes of Bac. Pathogens .............19

Fig. 4b:

Summary of Phenotypes of hfq Mutants of Pathogenic Bacteria ......................................20

Figure 5: Project Aims ......................................................................................................................24
Figure 6: pCR2.1 TOPO Vector .......................................................................................................26
Figure 7: pFC20K (HaLoTag 7) T7 SP6 Flexi Vector ....................................................................27
Figure 8: Schematic Diagram of Δ0228 Strain Generation .............................................................34
Figure 9: Schematic Diagram of 0228-HaLo Strain Generation .....................................................38
Figure 10: Schematic Diagram of Microarray Analysis ...................................................................44
Figure 11: Broad Overview of Immunoprecipitation Using 0228-HaLo ........................................50
Fig. 1seq. Amino Acid Alignment of PG0228 ................................................................................53
Fig. 2seq. Amino Acid Alignment of PG0228 in Distance Tree Formation ...................................54
Figure 12: Generation of Δ0228 Mutant DNA Fragment ................................................................58
Figure 13: Plasmid Screening with EcoRI Digestion ......................................................................59
Figure 14: PCR Amplification to Check for Mutant DNA Fragment ..............................................60
Figure 15: Δ0228 Mutant Selection by Amplification of Genomic DNA .......................................61
Figure 16: Amplification of PG0228 ...............................................................................................65
Figure 17: Digestion of pFC20K and pV2198 with EcoRI and XbaI ..............................................66
Figure 18: Transformation Colony Screening ..................................................................................67

vii

Figure 19: Amplification of the Mutant Construct ..........................................................................68
Figure 20: Annealing 0228-HaLo Construct to nusA Extension Using Fusion PCR .......................69
Figure 21: PCR Confirmation of 0228-HaLo Strain ........................................................................70
Figure 22: Growth Rate of Δ0228 Mutant Strain .............................................................................73
Figure 23. Survival Schematic ..........................................................................................................84
Figure 24: Photo of Δ0228 and W83 Colonies for Survival Study .................................................85
Figure 25: Survival Data ...................................................................................................................87

viii

LIST OF ABBREVIATIONS

Abbreviation

Definition

α

alpha

β

beta

Δ

delta

Δ0228

PGΔ0228

σ

sigma

°C

degree Celsius

µg

microgram

µL

microliter

BLAST

Basic Local Alignment Search Tool

BHI

brain heart infusion

cDNA

complementary DNA

DNA

deoxyribonucleic acid

dNTP

deoxyribonucleotide triphosphate

E. coli

Escherichia coli

FBS

fetal bovine serum

HN4

human oral epithelial cell line derived from SCC of tongue

LB

Luria Bertani broth

M

molar

min

minute

ix

mL

milliliter

MOI

multiplicity of infection

NCBI

National Center for Biotechnology Information

OD

optical density

PBS

Phosphate-buffered saline

PCR

Polymerase Chain Reaction

qRT-PCR

Quantitative Real-time Polymerase Chain Reaction

RNA

ribonucleic acid

SCC

squamous cell carcinoma

SDS

sodium dodecyl sufate

WT

wild type

ABSTRACT

THE CHARACTERIZATION OF PG0228 IN PORPHYROMONAS GINGIVALIS W83
By Courtney Danielle Schlenker
Bachelor of Science in Biology, University of Toledo, 2007
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Physiology and Biophysics at Virginia Commonwealth University.
Virginia Commonwealth University, 2011
Major Director: JANINA P. LEWIS, PH.D.
ASSOCIATE PROFESSOR, PHILIPS INSTITUTE OF OCMB
SCHOOL OF DENTISTRY
Periodontitis affects 10 to 15 percent of most adult populations and can contribute to
numerous systemic diseases. Porphyromonas gingivalis, a gram-negative anaerobic bacterium,
is a recognized prime causative agent in periodontitis. Studies have shown a number of small
non-coding RNAs (sRNAs) have been related to bacterial virulence. Many of these sRNAs
require the facilitation of the bacterial Sm-like protein, Hfq, for optimum function. Hfq is a RNA
chaperone involved in RNA stability, sRNA function, and polyadenylation. Mutants lacking in
Hfq often show pleiotropic phenotypes, although the extent and severity of hfq null
phenotypes is often species-specific. Hfq has been encoded by nearly half of eubacteria,
including pathogens. Based on a standard BLAST search, hfq has not been detected in P.
gingivalis. It is highly likely, however, that the bacterium possesses an Hfq homologue due to
its importance as an overall RNA cofactor. The P. gingivalis hypothetical protein, PG0228,
possesses the Sm-like protein motif, thus we believe it is an excellent Hfq candidate. Our goal

was to characterize PG0228 so we can gain a better insight into the function of this hypothetical
protein and determine if it indeed behaves like Hfq. Microarray analysis, growth studies, and a
survival study were done on a Δ0228 mutant to determine the biological role of the protein
encoded by PG0228. PG0228 was also tagged in vivo in order to determine if the protein binds
to RNA. Our results show P. gingivalis deficient in PG0228 show significant similarities to other
bacterium deficient in hfq. The Δ0228 strain showed significant sensitivity to host defense
mechanisms and an overall gene regulation in 15% of the genome. In addition, the mutant is
viable but produces a lower final cell density. Thus, we believe PG0228 is an excellent Hfq
candidate, and suggest further studies will show PG0228 is an Hfq homologue.
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Chapter 1: INTRODUCTION
1.1

Periodontal Disease
Periodontal diseases can contribute to systemic diseases including myocardial

infarctions, diabetes mellitus, adverse birth effects, nonhemorrhagic strokes, and
atherosclerosis[8;40;66;77;108]. Numerous studies show the gram-negative anaerobic
bacterium, Porphyromonas gingivalis is extremely important in initiating and progressing
advanced periodontal diseases. By fully understanding this bacterium and how it behaves, we
can better treat periodontal disease by lowering levels of P. gingivalis inside the oral cavity.
Periodontal disease is a group of infectious diseases affecting the structures surrounding
teeth. There are two stages of periodontal disease: gingivitis and periodontitis. Gingivitis,
which precedes periodontitis, is inflammation of gingival tissue resulting from accumulations of
plaque composed primarily of bacteria along the gum lining. Gums bleed easily during tooth
brushing or other stimulation. However, gingivitis is reversible with proper oral hygiene
practices. If left untreated, gingivitis can lead to periodontitis, the advanced stage of
periodontal disease. Periodontitis breaks down the supporting structures surrounding teeth,
including periodontal ligaments and alveolar bone, leading to tooth loss[15].
Periodontitis affects 10 to 15 percent of most adult populations[30]. The loss of
connective tissue surrounding the tooth increases pocket depth, a hallmark of periodontitis. As
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a result, the gingival tissue pulls away from the tooth enabling anaerobic bacteria to colonize in
the sub-gingival regions[105]. This causes a larger problem because bacteria in the sub-gingival
regions are not accessible by routine dental maintenance. The current treatment for
periodontitis is complete removal of the bacteria followed by treatment with antibiotics.
Problems with the current therapy include antibiotic resistance and recurrent infections[50].
Therefore, it is important we find new ways to treat the infections to more permanently rid the
sub-gingival area of these aggressive bacteria.
In severe cases of periodontitis, a highly permeable epithelial lining is the only defense
between virulent bacteria and the host’s underlying connective tissue and blood vessels. Once
in the blood stream, bacterial toxins and inflammatory mediators are carried to other parts of
the body. Recent studies have shown there is significant evidence an association between
periodontal infections and systemic diseases or conditions exists (see review,[28]). It is
suggested the periodontal pockets become a gateway for inflammatory mediators such as
cytokines tumour necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ) to enter
circulation, therefore linking periodontal infections with cardiovascular diseases, diabetes
mellitus, adverse birth outcomes, and pulmonary infections [33].
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Figure 1. Periodontal Diseases. This flow chart represents the stages of periodontitis
and examples of the systemic diseases which it is linked to.
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1.2.

Oral Microflora
Just like other places within the digestive tract, the oral cavity houses natural microflora.

Various bioinformatic approaches show there are over 700 species of bacteria living in the oral
cavity[71]. These bacteria usually have beneficial properties for the host. However, without
proper oral hygiene, these biofilms can accumulate to levels beyond homeostasis. Oral
microbial deposits along with extracellular components keeping microbial cells together are
commonly referred to as dental plaques. High level accumulations of dental plaque is
responsible for dental caries, periodontal disease, and peri-implantitis (inflammation affecting
tissue surrounding dental implants)[13;55].
Bacteria were first suspected to play an important role in gingivitis and periodontitis
starting in the 1960s (for review,[6]). Then, it was discovered that certain bacteria in plaque are
more important causative agents of periodontal infections. It is not simply the number of
plaques in the mouth but what constitutes the bacterial community. Bacterial species
Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Campylobacter rectus,
Micromonas micros, Streptococcus intermedius, Eubacterium nodatum, Aggregatibacter
actinomycetemcomitans, and Prevotella intermedia were found to be important in causing
periodontitis[6]. The three members of the red complex are Gram negative anaerobic bacteria.
Each expresses several virulence factors allowing it to set off the host immune response[11]. It
is essentially this host immune response that results in host tissue damage seen with
periodontitis. Studies have shown, the proportions of P. gingivalis, T. denticola, and T. forsythia
from sites of periodontal disease were significantly higher than normal tissue samples and
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therefore indicating these bacterial species are associated with local development of
periodontitis[60]. Currently, treatment approaches for severe periodontitis includes the
removal of these bacteria along with antibiotic treatment. Recurrent infections are a huge
problem with current treatment strategies because of the bacterium’s ability to become
resistant to antibiotics[50]. Better suited approaches need to be developed to reduce the
virulence potential of Porphyromonas gingivalis. This can only be done once we fully
understand this pathogenic bacterium.
1.3.

Porphyromonas gingivalis
Porphyromonas gingivalis is a black-pigmented, anaerobic, gram-negative bacterium

that is a prime causative agent in periodontitis[24;50;109]. P. gingivalis is classified in the
genus Porphyromonas, family Porphyromonadacae, order Bacteroidales, and class Bacteroides.
It is closely related to Bacteroides fragilis, but distantly related to E. coli. For this reason, the
traditional E. coli model gives limited information about P. gingivalis.
Along with diseased sites, P. gingivalis exists in healthy sites in the oral cavity such as
the tongue, palate, and supragingival tissue[20;76]. However, the amount of P. gingivalis is
increased in diseased and subgingival areas[63]. Several studies have stated P. gingivalis
produces many virulence factors. These factors modulate the host immune system and cleave
or degrade host cell proteins and surface receptors. This suggests that there is a delicate
balance between the bacterium and the oral mucosa allowing the organism to commensally coexist with its host (see review,[109]).
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Pathogenic P. gingivalis can adhere to, penetrate, and replicate in its host. The host’s
first line of defense is epithelial tissue. Epithelial cells have the ability to recognize and
eliminate infections before causing harm to the host. However, P. gingivalis has developed
ways to successfully remain viable within epithelial cells and cause severe problems. Studies
show the colonization of bacteria such as P. gingivalis in epithelium causes the gingival tissue to
secrete inflammatory cytokines and antimicrobial peptides setting off host immune
response[41]. Furthermore, P. gingivalis can replicate within the epithelium at high levels.
However, despite the number of intracellular bacteria, Porphyromonas gingivalis are able to
inhibit gingival epithelial cell apoptosis[110].
Colonizing P. gingivalis is significantly stressed when exposed to the host environment.
The bacteria must regulate its gene expression of virulent genes to survive in torturous host
conditions. Sensing and responding to changes in pH, temperature, oxygen exposure,
osmolarity, and redox potential allows for optimal growth and survival in host tissue[29]. It is
crucial virulence genes are turned on and off during infection by gene regulation.
Understanding gene regulation and expression in Porphyromonas gingivalis will provide better
information on periodontal disease pathogens.
1.4.

Gene Regulation in Porphyromonas gingivalis
The complete genome sequence of P. gingivalis strain W83 has been identified by the

Institute for Genomic Research[68]. Less is known, however, about its gene regulation.
Studies have shown there is expression of oxidative stress genes controlled by OxyR, a
regulatory protein, shortly after host infection[43]. RprY regulates genes involved in transport
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or oxidative stress[22]. Another gene, designated regT, is suggested to be involved in
regulating activity of major proteases at higher temperatures, called gingipains, which are
important in oxidative stress[99]. vimE (virulence-modulating gene E) is involved in modulating
the protease activity[100]. Despite these suggested modulators, gene and protein regulation
and activation in Porphyromonas gingivalis remains poorly understood. It is extremely unlikely
these few regulators are the only ones present in P. gingivalis.
1.5.

Regulatory small RNAs (sRNAs)
Strands of RNA look similar to DNA at first glance. However, functionally, these nucleic

acids are very different. RNA consists of a uracil instead of thymine and has a hydroxyl group at
the 2’ position of the aldopentose. DNA is double stranded leaving little room for conformation
changes. On the other hand, most RNA is single stranded allowing it to fold. The ability for RNA
to fold back on itself produces diverse structures which allow RNA to carry out several
important cellular functions.
Regulatory bacterial small ribonucleic acids (sRNAs), also known as non-coding RNAs,
are not translated into proteins. They are found in both prokaryotes and eukaryotes [7] but
small RNAs are not ribosomal, transfer, or messenger RNAs. It is accepted most sRNAs are vital
post-transcriptional regulators of gene expression in response to environmental changes and
may be involved in numerous cellular processes including cell development, growth,
differentiation, and death by turning genes on and off[1;16;46].
Pathogenic prokaryotic sRNAs have recently become a hot topic because some have
been related to bacterial virulence. It is suggested less energy is expelled by the cell using
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sRNAs compared to synthesizing bulky regulatory proteins in response to environmental
stress[4]. Because these RNAs are small and untranslated, they are more cost effective which
allows for a fast response to external stimuli and fast recovery once the external stimulus is
removed[82].
In the past, gene regulation research has focused on transcriptional regulation and
protein-protein interactions. However, small RNAs regulate gene expression at the post
transcriptional level by base pairing with mRNA transcripts. This binding of sRNA with mRNA
influences translation or mRNA stability therefore upregulating or downregulating gene
expression[72].
Small RNAs have been extensively studied in species like Escherichia coli. These
molecules range from 50-400 nucleotides long and many are evolutionary conserved. So far,
there have been about 80 known sRNAs identified just in E. coli. For example, OxyS RNA acts as
a global regulator and is activated in response to oxidative stress in E. coli. By an antisense
mechanism, OxyS regulates the expression of as many as 40 genes, including the rpoS σ subunit
of RNA polymerase and fhlA. OxyS regulates fhlA by pairing with a short segment of the ShineDalgarno sequence blocking ribosome binding[5]. DsrA is another example of a sRNA
discovered in E. coli. DsrA regulates two transcriptional regulators: HN-S, a histone-like protein
that silences several bacterial genes, and RpoS σ, the stationary phase sigma factor of RNA
polymerase[4]. These are just two examples of sRNA and already there are two levels of
regulation for just RpoS σ. The sRNA can regulate one or many target genes. Plus, the mRNA
targets can be regulated by several sRNAs creating extensive overlap, further complicating the
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global regulation. However, the molecular functions of many of these sRNAs are still not
known[82]. Plus, even though sRNAs in E. coli have been extensively studied, little is known
about sRNAs among distant species, specifically Porphyromonas gingivalis[72].
Binding sRNA with their mRNA targets influences translation or mRNA stability. The
antisense sRNA regulators are either cis or trans-acting. The RNA-encoding gene overlaps with
the target gene in cis regulators. There is only one target gene and there is complete
complementarity between the regulator and target. On the other hand, trans-acting regulators
are found at loci distant to their target genes. Trans regulators are not completely
complementary and regulate by imperfect duplexes. The imperfect complementation of transacting sRNAs with specific mRNAs allows these sRNAs to regulate multiple targets[4]. Plus,
extensive research has revealed there is a crucial third party to this equation, proteins. Specific
proteins, notably Hfq, interact with the sRNAs acting as a catalyst, induce sRNA changes in
conformation, or are sequestered by the sNRA to inhibit protein action.
1.6.

Sm Family of RNA-Associated Proteins
The Sm protein family consists of Sm and Sm-like proteins that bind to RNA in bacteria,

Archaea, and eukaryotes. These proteins assemble in heteromorphic or homomorphic six or
seven member ring complexes. The Sm family is characterized by the Sm motif which allows
the protein to bind to its neighboring subunits to form a central pore. The central pore binds to
short uracil-rich stretches of RNA[95].
Sm proteins were first discovered in the 1960s. A patient, Stephanie Smith, diagnosed
with systemic lupus erythematosus (SLE), produced antibodies to a set of proteins in the
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nucleus. The proteins were given the name, Sm, in her honor. It was later discovered these
eukaryotic proteins formed protein-RNA complexes and called them small nuclear
ribonucleoproteins (snRNPs), which are involved in a variety of RNA-processing functions. In
prokaryotes, structure studies reveal that Hfq possesses the Sm-motif found previously only in
eukaryotes and archaea. In prokaryotes, however, Hfq forms a homo-hexameric ring unlike
the heptameric Sm rings found in eukaryotes and archaea[95].
1.7.

Hfq protein
Sm-like proteins are important in RNA processing, splicing, and messenger RNA decay.

One Sm-like protein, Hfq, has been identified in bacteria and bears a striking resemblance to
Sm-like proteins both structurally and functionally[61;78]. Hfq is an RNA chaperone involved
RNA stability, small RNA function and polyadenylation[48]. Hfq (also known as HF-I) was
originally identified as a host factor required for the replication of the bacteriophage Qβ-RNA in
the 1960s[31;32;81]. Following its discovery, decades of research focused on the protein’s
binding features[21;79]. At this time, it was suspected this highly conserved protein must hold
an important role in cellular function. Why else would bacteria conserve a protein if its sole
purpose is to allow for viral infection? It wasn’t until the early 1990s, Hfq received significant
attention when it was discovered that it acts as a key global regulator of gene
expression[65;97]. New functions of this fascinating regulator are being identified all the time
but it could be years until we fully understand its limits.
The Hfq gene is highly conserved among bacteria but has been extensively researched in
E. coli [90] and was first discovered as a gene regulator when geneticists disrupted the gene in
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E. coli. The hfq null mutant showed pleiotropic phenotypes, including decreased yields,
increased cell size, osmosensitivity, and increased sensitivity to UV light[97]. Interestingly,
some of these phenotypes caused by the hfq null mutant were the same as defects caused by
rpoS (gene encodes stationary phase sigma factor, σS) mutations. The E. coli σS activates genes
involved in stress-protective functions including resistance against oxidative stress, UV
irradiation, and hyperosmolarity[42]. It was then found that Hfq was involved in the regulation
of expression of σS subunit of RNA polymerase and therefore all σS-independent genes in E. coli
and Salmonella typhimurium[65]. The E. coli Hfq binds the sRNAs transcribed by genes rprA,
dsrA, and oxyS. All three of these sRNAs regulate the translation of rpoS gene, which encodes
the σS subunit, thus having indirect control of σS translation.
However, some pleiotropic phenotypes caused by the hfq null mutant could not be
explained by a lack of rpoS expression indicating Hfq does more than regulate translation of
rpoS gene. Further experiments showed that Hfq’s interaction with other RNAs, thus allowing
these small RNAs to interact with their targets[59;61]. For instance, Hfq represses the
translation of E. coli ompA gene by interfering with ribosomal binding, resulting in degradation
of ompA messenger RNA[61]. It was also shown Hfq is involved in poly(A) tail metabolism by
stimulating polyadenylation and is essential for growth at temperatures of 45°C and
above[9;39;96].
Hfq is considered to act as a global gene regulator, its primary function facilitating the
interaction of sRNAs with their target mRNAs. Inactivation of Hfq reduces the translation of
stress σS factor, induces the σ E-dependent envelope stress response in Salmonella enterica and
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E. coli, and reduces expression of the σ32 mediated cytoplasmic stress response[26;37;94].
There have also been reports Hfq interacts with tRNAs[14]. Since then, several more sRNAs
have been shown to associate with Hfq or need Hfq for transcriptional control of its target
mRNAs[104]. For example, DsrA and RyhB require Hfq for their stabilization[56;83]. Hfq
binding protects DsrA and RyhB from cleavage by RNase E, which is an endonuclease involved in
mRNA decay and tRNA processing. Hfq may bind to other riboregulators as well because Hfq
may bind to the same sites as RNase E (see review,[98]).
Hfq also directly facilitates the interaction between sRNA and their RNA target as it does
with OxyS and Spot 42[61]. As previously stated, OxyS RNA is transcribed in response to
oxidative stress. Importantly, Hfq increases the efficiency of OxyS by increasing the interaction
between OxyS and its target mRNAs by directly facilitating OxyS but Hfq does not affect OxyS
stability. Meaning, Hfq does not stabilize OxyS but Hfq is extremely important for OxyS to do its
job. OxyS downregulates the translation of rpoS and fhlA and therefore translation of rpoS and
fhlA would be upregulated without Hfq regulation. Moreover, the upregulation of rpoS and
fhlA could not be restored by mutating OxyS[111]. Spot 42 regulates gene expression of the
galactose operon by antisense mechanism on galK. Hfq also binds to galK but Hfq does not
change the structure of Spot 42 RNA. It is suggested Hfq and Spot 42 RNA both bind to target
RNA, galK, producing a complex including RNA-RNA and RNA-protein interactions[62]. The
third gene in the galactose operon, galK, is targeted by Spot 42 RNA repressing translation. In
the presence of Hfq, there is a 150 fold increase in the interaction between Spot 42 and galK
compared to the absence of Hfq.
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Figure 2. Examples of Hfq regulation in E. coli
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The expression of Hfq is regulated by transcriptional and post-transcriptional control (no
evidence for post-translational control). Its internal promoters ensure Hfq is expressed during
stress conditions (see review,[98]). During stress conditions, there is a greater incidence of
misfolded proteins intracellularly, therefore becoming detrimental to the bacteria’s health.
Experiments also demonstrate Hfq has the ability to modulate the rate of its own expression.
Modulation is done by decreasing the stability of its mRNA. This suggests there is a negative
feedback mechanism decreasing expression when Hfq accumulates[102]. The expression rate
of Hfq during stress responses has competing results. Azam et al showed there are a large
number of Hfq molecules per cell expressed during log phase reaching 50,000-60,000. This
number decreases by half during transition to stationary phase (phase when growth and death
rate are equal)[2]. However, studies have shown Hfq is elevated during transition to stationary
phase and times of slow growth in comparison to log phase[103].
The function of Hfq may also be regulated by its interaction with other proteins. Hfq
interacts with several proteins including RNases, helicases, Rho-factor, ribosomal proteins, RNA
polymerase in the presence of S1 protein, and poly(A)polymerase (PAP I)[17;64;89]. Hfq
stimulates the synthesis of poly(A) tails by protecting the poly(A) tails from degradation by
exoribonucleolytic degradation[73]. Plus, studies have shown the majority of Hfq associated
with translational machinery inside the cell but a small percentage is present associated with
the nucleoid. Hfq has been identified as a DNA binding protein that affects negative
supercoiling[93].
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Like it is with most proteins, the function of Hfq is related to its structure. As stated, Hfq
can associate with a variety of RNAs by binding to their A/U-rich sequences and is largely
nonpolar[78]. Hfq forms a homo-hexameric ring with each subunit consisting of a five-stranded
antiparallel β-sheet with an N-terminal α-helix[78]. It is interesting to note, even though there
is little sequence homology between Hfq and Sm/Lsm monomers, their structures are quite
similar. RNA binds in a circular shape inside the pore of the Hfq hexameric protein. The
sequence recognized by Sm proteins is 5’-AUUUUUG-3’ and it binds to six binding pockets
within Hfq’s pore (excluding the 3’G). Although there have been specific sequences identified
for Hfq targets ompA, DsrA, OxyS, and Spot 42, no single motif has been identified. There are
two proposed mechanisms of how Hfq-RNA interactions allow for Hfq to act as a facilitator of
RNA. First, the target site of single-stranded RNA is unwound when interacting with the pore of
Hfq, most likely destabilizing surrounding nucleotides on the RNA strand. This would allow for
these surrounding RNA nucleotides to create new RNA-RNA interactions. Second, there are six
identical binding pockets within the Hfq pore which would suggest Hfq can bind to more than
one RNA at a time. This would jumpstart interactions between sRNAs and their target mRNAs if
both bound to the Hfq facilitator (See review,[98]).
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(a)

(b)

(c)

Figure 3. Structure Summary of Hfq From Pseudomonas aeruginosa. Structures from the (a)
front and (b) side are shown. The sequence and alignment (c) of all six sequences are also
shown. Information has been taken from NCBI (http://www.ncbi.nlm.nih.gov/Structure).
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Given the numerous studies on Hfq, one can infer Hfq acts an important cofactor for
regulatory RNAs; for a review, see[98]. Hfq interacts with many trans-encoded RNAs. As
stated, these regulatory RNAs do not have complementary interactions with their targets thus
allowing them to recognize many target strands. Hfq enables these sRNAs to more efficiently
act on targets by changing the RNA’s structure, affect stability, and facilitate complex
formation. This is most likely the reason Hfq acts in such a species-specific manner, making it is
hard to predict the exact genes Hfq will regulate within each bacterial species.
Hfq is continually being discovered in a wide range of bacteria. So, far, Hfq candidates
have been identified in at least half of all sequenced bacterial genomes[18]. Among bacterial
species, the protein varies in length from 70-100 amino acids but the Sm motif is located in the
N-terminal in all cases implying the C terminal is not important for the function of the protein.
Interestingly, the species Novosphingobium aromaticivorans encodes tandem Hfq sequences
(193 amino acids) that form dimers instead of homo-hexamers. Plus, duplicated copies of Hfq
are found in species Bacillus anthracis and Ralstonia metallidurans[90]. Even though Hfq is
highly conserved among bacteria, Porphyromonas gingivalis does not appear to have Hfq.
Based on BLAST searches, there is no open reading frame encoding Hfq in P. gingivalis,
Cyanobacteria, green sulphur bacteria, some proteobacteria, several Gram-positive bacteria,
and Chlamydia[18]. It is unlikely this information means there are no Hfq orthologues in these
bacteria. Several trans encoded sRNAs are highly conserved among bacteria and numerous
studies show Hfq is imperative to their function. Plus, the level of sequence homology is varied
considerably within the Sm/Lsm family, including a low sequence homology between speciesspecific Hfq proteins. The motif consists of four to seven highly conserved amino acids and a
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pattern of hydrophobic and hydrophilic residues. Also, studies have shown different residues
can bind to RNA. For instance, one of the Hfq proteins in Bacillus anthracis and Ralstonia
metallidurans contains a Lys-His sequence that binds to RNA while the other Hfq protein in
these bacteria both contain a Lys-Gln or Lys-Arg conserved sequence. Even though both of
these sequences on Hfq bind RNA, a standard BLAST search would not reveal both Hfq
proteins[98]. As stated, new Hfq candidates are being discovered with new combinations of
sequences that still form perfect conservation of the Sm motif similar to those of the S. aureus
and E. coli Hfq structures that were first discovered. This further suggests the amino acid
sequence of Hfq can differ extensively between bacterial species making it impossible to
determine certain species don’t have Hfq based solely on a BLAST search. Because of this
information, we believe Porphyromonas gingivalis protein PG0228 is an excellent Hfq
candidate. PG0228 does not have sequence homology with “traditional” Hfq. However,
structure analysis shows this conserved hypothetical protein has a Sm-like motif, one of the few
things Hfq proteins from different bacteria have in common. By characterizing PG0228 in this
study, we will be able to determine if it indeed behaves like Hfq.
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Figure 4a. Presence or absence of an hfq gene in completed genomes of
bacterial pathogens. Data were obtained from NCBIGenome database in July 2009.
Table has been taken from Chao et al. [18].
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Figure 4b.
Summary of
Phenotypes of
hfq Mutants of
Pathogenic
Bacteria. Table
has been taken
from Chao et
al. [18].
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Chapter 2: MATERIALS AND METHODS
2.1.

Project Aims

1. Determine the biological role of the protein encoded by PG0228.
a. PGΔ0228 mutant (abbreviated Δ0228) is generated by fusion PCR techniques.
Areas downstream and upstream of PG0228 on the chromosome are amplified
using P. gingivalis W83 strain genomic DNA and general PCR methods. Then,
ermF cassette is inserted in between the two amplified segments therefore
deleting the PG0228 from the W83 DNA segment. The DNA segment is ligated
into a plasmid vector and then inserted into the W83 genome by a double crossover into the chromosome thus replacing PG0228 with ermF. The 0228 null
mutant is verified by PCR amplification, enzyme digestion, and sequencing.
b. A growth curve is done to assess the growth of the Δ0228 mutant compared to
the wild type. Both the growth rates and overall densities of the two strains are
compared.
c. Then, changes in transcription profile are studied using microarray analysis.
Both W83 and Δ0228 are grown under the same conditions together. Their RNA
is isolated and reverse transcribed into cDNA and labeled. The cDNAs from both
strains are mixed and hybridized onto microarray slides containing probes for all
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ORF present on the W83 genome. Microarray slides are scanned and analyzed to
identify the genes upregulated and downregulated in the Δ0228 mutant.
d. Changes in host invasion rates and survival can be measured by a survival study.
Epithelial cells are infected with wild type and Δ0228 Porphyromonas gingivalis
for 30 minutes. Bacteria sticking on the surface of epithelial cells are washed off
and then killed with an antibiotic while internalized bacteria remain unaffected.
Epithelial cells are then lysed and their contents are plated onto Blood agar
plates in anaerobic conditions. The viable intracellular bacteria grow a certain
number of colonies, therefore indicating if PG0228 has influence on bacterial
survival during host invasion.
2. Determine if the protein binds to RNA
a. The 0228-tagged fusion mutant (0228-HaLo) is also generated by fusion PCR
techniques. PG0228 is inserted into a Halo plasmid vector containing “tag”. Erm
cassette (ermF-ermAM) is then inserted. DNA segment containing gene, tag, and
erm is amplified by general PCR along with a segment downstream of PG0228.
The two segments are ligated by Fusion PCR methods. The DNA construct is
then ligated into a plasmid vector and inserted into the W83 genome by a
double cross-over into the chromosome. The 0228-HaLo strain is verified by PCR
amplification and sequencing.
b. 0228-HaLo strain is treated with formaldehyde and immunoprecipitation is
carried out to study RNA-protein interactions in vivo. The cross-linked 0228/RNA
is immunoprecipitated using the HaLoTag Resin. The RNA bound to PG0228 is
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then sequenced, therefore indicating if PG0228 is a RNA binding protein and if
so, the identities of these bound RNAs.
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Figure 5. Project Aims. This is a flow chart identifying the focus of this study.
AIM 1: Determine the biological role of the protein encoded by PG0228
AIM 2: Determine if the protein binds to RNA
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2.2.

Bacterial Strains and Plasmids

Porphyromonas gingivalis W83 strain was used as the wild type for this study. This strain is
known to contain a compliment of known virulent factors. Strain W83 (also known as strain
HG66) was sequenced by The Institute for Genomic Research (TIGR) and general properties can
be found at the Los Almos National Laboratory Bioinformatics (ORALGEN)
(http://www.oralgen.lanl.gov). The genomic DNA sequence includes 2, 343,479 base pairs with
a G+C content of 49%.
For cloning purposes, the pCR2.1-TOPO Vector (Figure 6) or pFC20K T7 SP6 Flexi Vector
(Figure 7) was mixed with the desired PCR product for ligation. All transformations were
performed using One Shot TOP10 Chemically Competent Escherichia coli.
2.3.

Growth Conditions and Media

All P. gingivalis strains were grown on blood agar plates (TSA II, 5% Sheep Blood) (BBL,
Cockeysville, MD) containing 0.5-1% clindamycin. The liquid cultures were grown in BHI (brain
heart infusion, Difco Laboratories, Detroit, MI) media supplemented with hemin (2µg/mL)
(Sigma-Aldrich, St. Louis, MO) added. P. gingivalis was grown in anaerobic conditions in an
atmosphere composed of 10 % Hydrogen, 10% Carbon dioxide, and 80% of Nitrogen at 37°
Celsius.
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Figure 6. pCR2.1 TOPO Vector. Vector used to introduce mutant PCR fragment into TOP 10
E. coli chemically competent cells. The vector equals 3.9 kb and includes 3’-T overhangs for
ligation PCR products using Taq Polymerase. EcoRI sites flank the PCR product insertion site
for easy excision of inserts. The vector also contains kanamycin and ampicillin resistance
genes for selection in E. coli.
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Figure 7. pFC20K (HaLoTag 7) T7 SP6 Flexi Vector. The HaLoTag was used to introduce
0228 with HaLoTag and ermF-ermAM into TOP 10 E. coli chemically competent cells. The
vector itself is 4.4 kb. The insertion of the PCR product (0228) is added between the SgfI
and EcoICRI sites. The vector can only be introduced to E. coli once the lethal barnase
gene is replaced with the PCR gene of interest. The vector also contains a kanamycinresistance gene for selection purposes.
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Table 1. Primer Sequences.

Segment

Name

Primer Sequence

Tm (°C)

Mut1F

5’ GTC CCG AAA GAC GGA GAA T 3’

55.2

Mut1R

5’ CCC CCG GGG GCC CCC CTG TCG AAG C 3’

75.4

Mut2F

5’ GGG GGG GGG GGG GGG TAG TCA TGG 3’

74.1

Mut2R

5’ TTG AGG AAC TCT CCG CTT GT 3’

56.2

ExtF

5’ GGG GGG GGG GGG GGG ATC GCT GGC 3’

73.5

ExtR

5’ CTC TTC GGC ATC AGG AGT TC 3’

55.3

ErmF1

5’ CGA TAG CTT CCG CTA TTG CT 3’

54.8

ErmR2

5’ CCC CCC CCC CCC CCC TTT TAC GTT TC 3’

73.2

CF2

5’ GAC TGC AGC TAG TCT AGA GCT CCC GA 3’

66.2

CR2

5’ GAA TCA GAT CGC AGC TGC AGG TCG C 3’

69.1

RP-Erm

5’ GTC CAC CAT GGG AAG CTG TCA GTA GT 3’

63.2

FP-Erm

5’ GTC GAC ATA TGC CGA TAG CTT CCG CT 3’

64.0

Mut1

Mut2

Ext

ermF

PG0228

ermFermAM
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2.4.

Generation of P. gingivalis Mutant Strains

Two mutant strains, labeled Δ0228 and 0228-HaLo, were constructed for the purpose of this
study in order to characterize gene PG0228. The Δ0228 strain was obtained for the purpose of
characterizing a genetic knockout of PG0228 compared to wild type strain, W83. The 0228HaLo was created to see if protein PG0228 is an RNA binding protein. Each mutant strain was
verified by gel electrophoresis, PCR, restriction enzyme digestion, and sequencing.
Fusion PCR techniques [91] can be used to replace genes, tag genes, or replace promoters
by introducing the proper selective cassette, thus, was the major method used to generate
both mutants. For each round of PCR amplification, W83 genomic DNA was used as the DNA
template and Platinum Taq HiFidelity Polymerase (Invitrogen, Carlsbad, California) was the
enzyme chosen. All PCR purifications of PCR products were done using the MinElute PCR
Purification kit from QIAGEN (Valencia, CA) or the GeneJET PCR Purification Kit from Fermentas
(Glen Burnie, MD). Both worked equally well for all experiments.
2.5.

Generation of Δ0228 Mutant Porphyromonas gingivalis Strain

P. gingivalis genomic DNA was used to amplify flanking DNA fragments (labeled Mut1 and
Mut2 for reference). Primers Mut1F and Mut1R (see Table 1 for primer sequences) were used
to amplify fragment Mut1 and primers Mut2F and Mut2R were used to amplify Mut2. The
vector, pV2198 carries the 2kb ermF-ermAM antibiotic resistant gene cassette[27], therefore,
was the template DNA used to amplify erm cassette. The first 1kb of this cassette containing
clindamycin resistance was amplified, labeled ermF, using primers ErmF1 and ErmR2.
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The Platinum Taq DNA Polymerase High Fidelity protocol was followed with a sample size of
25µL. Each PCR sample contained 2.5 µL of 10X High Fidelity PCR Buffer, 0.5µL of 10mM dNTP
mixture, 2µL of 50mM MgSO4, approximately 100ng of Genomic DNA, 0.2µL of Platinum Taq
HiFidelity polymerase, and autoclaved, distilled water. The tubes were then capped and
centrifuged for a short time to mix all the contents. The thermal cycler was run for 30 cycles.
The first cycle heated the sample to 94°C for 2 minutes. Cycles 2-30 included denaturing the
sample at 94°C, annealing the strands at 55°C, and extending strands for 2 minutes at 68°C.
Next, 5µL of the PCR products were run on a 1% agarose gel electrophoresis using 1X TAE
buffer. For visualization of DNA strands, the gel was stained with ethidium bromide. The
desired PCR products were then purified using the MinElute PCR Purification kit from QIAGEN.
The purified flanking DNA fragments from the first round of general PCR were annealed
together through fusion PCR techniques [91] using Mut1, ermF, and Mut2 fragments as
template DNA. Fragment Mut1 sits upstream of ermF and Mut2 sits downstream of ermF
totaling a length of 2.1kb. The original primers Mut1F and Mut2R were used for amplification
of the desired fusion PCR product.
The Platinum Taq DNA Polymerase High Fidelity protocol was followed with a sample size of
25µL. Each PCR sample contained 2.5µL of 10X High Fidelity PCR Buffer, 0.5µL of 10mM dNTP
mixture, 2µL of 50mM MgSO4, approximately 100ng of Genomic DNA, 0.4µL of Platinum Taq
HiFidelity, and autoclaved, distilled water. The tubes were then capped and centrifuged for a
short time to mix all the contents. The thermal cycler was run for 35 cycles. Cycle 1 heated the
sample to 94°C for 2 minutes. Cycles 2-35 denatured the sample at 94°C, annealed at 57°C, and
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had an extension time of four and a half minutes with a temperature of 68°C. The size of the
PCR product was confirmed on a 1% agarose gel, and purified.
Transformation and Cloning
Once the desired PCR fragment was produced, the product was cloned into the pCR2.1TOPO Vector (Figure 6) according to the manufacturer’s protocol (Invitrogen). First, a reaction
containing PCR products, vector, salt, and sterile water were combined and incubated for five
minutes at room temperature. The reaction was then placed on ice until transformation. The
TOPO cloning reaction was added to One Shot TOP10 Chemically Competent Escherichia coli
and gently mixed. Then, the mixture was placed on ice and incubated for 30 minutes. The cells
were heat-shocked at 42°C for 30 seconds and transferred back on ice. S.O.C. medium was
added in sterile conditions. The culture was grown at 37°C in a shaker for one hour. The
transformation was then spread onto a pre-warmed selective LB plate supplemented with X-gal
and kanamycin (50µg/mL) and grown overnight at 37 °C.
Positive white colonies were cultured in LB media overnight at 37°C in a shaker. Plasmids
were isolated from the E.coli using QIAprep Spin Miniprep kit and digested with EcoRI enzyme.
The digestion incubated at 37°C for approximately 2 hrs and then separated on a 1% agarose
gel in 1X TAE buffer. Correct PCR plasmids were verified by sequencing done by DNA Core
(MCV-VCU Nucleic Acids Research Facilities, Richmond, VA).
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Electroporation of DNA into P. gingivalis
Transformation of the desired PCR products was done using electroporation into P.
gingivalis to obtain the Δ0228 mutant strain. A 10µL sample of construct DNA was added to
100µL of EP competent cells. A control containing only EP cells was also used. These samples
were incubated on ice for around five minutes. The samples were electroporated for several
seconds at 2.5 volts. The low range registered 400 and high range registered 800. Immediately,
500µL of BHI + hemin was added to the mixtures within the anaerobic chamber to grow
overnight. The cultures were then plated on blood agar plates with 1% clindamycin to grow for
up to one week. Colonies obtained on the plates were characterized for the presence of
correct organization of the genetic locus as described below.
Colonies on the blood agar plate were labeled and inoculated on two new blood agar
plates; one plate contained 1% clindamycin antibiotic and one plate contained no clindamycin.
The plate containing the antibiotic was left inside the anaerobic incubator. The plate with no
antibiotic was taken out of anaerobic conditions and was incubated at 37°C to check for aerobic
bacterial contamination. The positive colonies from the electroporation were also cultured into
8mL of BHI + hemin to grow overnight. 3mL of the culture was saved at -80°C in DMSO and 5mL
was used for genomic DNA isolation.
Genomic DNA isolation
The 5mL of culture was spun down at 6000rpm for ten minutes to form a pellet. The
supernatant was extracted. The genomic DNA was isolated using Puregene DNA Purification
System (Gentra Systems, Minneapolis, MN) according to manufacturer’s protocol. Then, 3mL of
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lysis solution was added to pellet and mixed until cells are suspended. The cells were lysed at
80°C for 5 min and 15µL of RNase solution (product from Sigma-Aldrich, St. Louis, MO) was
added to the suspension. It was mixed by inversion, and then incubated for 15-60min at 37°C.
Then, 1mL of protein precipitation solution was added to the lysate after solution cooled back
to room temperature. Mixture was then vortexed at high speed for 20 seconds to mix solution
with cell lysate.
Protein and cell fragments were separated from DNA by centrifuging at 6000rpm for 13
minutes. The supernatant containing DNA was extracted and put into clean 15mL tube
containing 3mL of 100% isopropanol. Contents were mixed by inverting and then centrifuged
at 2000rpm for 3 minutes. This caused DNA to form a small white pellet. Supernatant was
removed and drained on clean absorbent paper. Next, 3mL of 70% ethanol was added to wash
the DNA. The sample was again centrifuged for 1min at 2000rpm. Ethanol was removed and
drained on clean absorbent paper. Then, 500µL of DNA hydration solution was added and
incubated for 1hr at 65°C and overnight at room temperature.
The isolated genomic DNA was run through a PCR to check for correct band size. The PCR
was run with an annealing temperature of 57°C and extension time of 4 minutes using
AccuPrime Taq DNA Polymerase (Invitrogen). The size of the PCR product was confirmed on a
1% agarose gel and then purified. The PCR samples were verified by sequencing done by DNA
Core (MCV-VCU Nucleic Acids Research Facilities, Richmond, VA).
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Figure 8. Schematic Diagram of Δ0228 Strain Generation. Upstream and downstream
regions of PG0228 were amplified. ermF cassette is inserted using fusion PCR.
Desired fragment is integrated into the W83 genome by electroporation. The map of
PG0228 genomic locus is adapted from Oralgen (http://www.oralgen.lanl.gov).
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2.6.

Generation of 0228-HaLo Porphyromonas gingivalis Strain

The 0228-HaLo mutant was created in order to determine whether or not the protein
PG0228 indeed binds to RNA. 0228-HaLo does not contain any genetic deletions and behaves
as wild type. 0228-HaLo contains an additional manufacturer-engineered HaLoTag (1Kb)
(Promega, Madison, WI) downstream of PG0228 and an insert of the ermF cassette (1Kb) for
mutant selection. The HaLoTag was added for specific protein selection by HaloLink Resin (also
engineered by Promega) according to manufacturer’s protocol during immunoprecipitation.
First, the primers CF2 and CR2 (see Table 1 for sequences) were used to amplify PG0228
using general PCR. Specific primers were selected based on manufacturer’s suggestions.
Specific primers for PG0228 were intended to produce 3’ overhangs for easy insertion into our
desired vector, pFC20K (HaLoTag 7) T7 SP6 Flexi Vector between SgfI and EcoICRI restriction
sites (Figure 2.2). The size of this PCR product was confirmed on a 1% agarose gel. After
pFC20K was digested with SgfI and EcolCRI, PG0228 was inserted between SgfI and EcoICRI
sites.
To insert the ermF-ermAM cassette into pFC20K between EcoRI and XbaI, pV2198 was
digested with EcoRI and XbaI. The digestion mixture incubated at 37 °C for 2 hours and was
confirmed on a 1% agarose gel. The 2.1kb band ermF-ermAM was extracted under UV light
from the pV2198 digestion and purified using the MinElute Gel Extraction Kit (QIAGEN)
protocol. Six volumes of QG buffer per volume of gel were added. The surrounding gel was
dissolved with an incubation of 50°C for 10 minutes, mixing every 2 minutes. One volume of
isopropanol was added to the mixture, mixed, and placed into a MinElute column. The column
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was centrifuged for 1 minute at 14,000rpm and the flow through was discarded. Next, 500µL of
buffer QG was added. The column was again centrifuged for 1 minute and flow through was
discarded. Next, 750µL of Buffer PE was added to wash, then centrifuged, and flow through
was discarded. The column was centrifuged for 2 minutes to empty out the residual buffer.
The column was placed in a new tube and 10µL of EB Buffer was added. The mixture was left
for one minute and then centrifuged for one minute. This time the flow through was kept
because it contained the ermF-ermAM fragment.
The plasmid pFC20K T7 SP6 Flexi Vector (Promega Corporation, Madison, WI) contains the
HaLoTag and was also digested. Digestion of plasmid pFC20K T7 SP6 with EcoRI and XbaI
allowed ermF-ermAM antibiotic resistant gene to be inserted into the pFC20K vector
downstream of the HaLoTag fusion protein.
The DNA plasmid pFC20K T7 was then transformed into One Shot TOP10 Chemically
Competent Escherichia coli according to the Invitrogen protocol (as described above). Positive
white colonies were cultured in LB media overnight at 37°C shaking. Plasmids were then
isolated from the E.coli using QIAprep Spin Miniprep kit (QIAGEN).
Next, a general PCR was run to amplify the DNA of interest. CF2 and ermR2 primers (see
Table 1 for primer sequences) were used to amplify PG0228, HaLoTag, and ermF (ermF is only
the first 1kb of the 2.1kb ermF-ermAM cassette containing clindamycin resistance). The PCR
was run at an annealing temperature of 55°C, extension time of 3 minutes, and an enzyme
temperature of 68°C. The size of the PCR product was confirmed on a 1% agarose gel and then
purified.
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The gene downstream was then added to the PCR fragment to ensure a double crossover.
First, a general PCR was run to amplify the gene downstream of PG0228, PG0229 (nusA). Both
ExtF/ExtR primers (see Table 1 for sequences) were used for the PCR. The PCR was run at an
annealing temperature of 55°C, an extension time of 2 minutes, and at an enzyme temperature
of 68°C. The size of the PCR product was confirmed on a 1% agarose gel and then purified.
A fusion PCR was then run to anneal the fragments together[91]. The fusion PCR included
primers CF2 and ExtR, an annealing temperature of 58°C, and an extension time of 5 minutes at
68°C. The fragment was confirmed on a 1% agarose gel. The product was cloned into the
pCR2.1-TOPO vector according to the protocol (Invitrogen). The TOPO cloning reaction was
then added to One Shot TOP10 Chemically Competent Escherichia coli. Positive colonies were
cultured overnight and plasmids were isolated by mini prep. Correct PCR plasmids were
verified by sequencing done by Retrogen Inc. (San Diego, CA).
The Fusion PCR products were also electroporated into P. gingivalis using the protocol
described previously. A fraction of the LB culture was frozen at -80°C and another fraction
harvested for genomic DNA isolation. The isolated genomic DNA was run through a PCR to
check for correct band size. The PCR was run with an annealing temperature of 58°C and
extension time of 3 minutes using Platinum Taq HiFidelity polymerase. The size of the PCR
product was confirmed on a 1% agarose gel electrophoresis using 1X TAE buffer.
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Figure 9. Schematic Diagram of 0228-HaLo Strain Generation. PG0228 and ermF-ermAM
are inserted into pFC20K. PG0228, HaLoTag, and ermF are amplified along with the 5’ of
nusA. Both strands are annealed together by fusion PCR. The desired fragment is
transformed into W83 genome by electroporation.
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2.7.

Growth Curve of Δ0228 Mutant

A growth curve was done to assess the growth of the mutant compared to the wild type.
Each culture was left to grow overnight. Quantitative results were obtained by checking optical
density at 660nm. Each sample was diluted to an optical density (OD660nm) of 0.1 in a total of
7mL of BHI + hemin media. Both W83 and Δ0228 were grown in triplicates. The growth was
measured for 24hrs in 4hr increments (8hrs for the 16-24hr time block).
2.8.

Microarray Analysis of Δ0228 Mutant

RNA Isolation
Overnight cultures of W83 and Δ0228 were diluted to an OD660nm of 0.2 and grown to an
OD660nm of 0.5. First, 5mL cultures were collected by centrifugation for 15 minutes @4°C, and
spun at 6000rpm. Cells were then saved in -80°C freezer. Total RNA was isolated from pelleted
cultures (protocol from Karl M. Thompson, Ph.D.). Pellets were resuspended in 500µL of 1X
lysis buffer and placed on ice. An equal volume of hot acid phenol-chloroform was added to
samples. Then, samples were placed on a heat block at 65°C for 10 minutes. Solution was
mixed by inversion every two minutes during heating process. Samples were spun for 10
minutes at 10,000rpm. The supernatant was transferred to a new Eppendorf tube, and then
mixed with an equal volume of acid phenol-chloroform. This step was repeated until there was
no interface visible.
The sample was then mixed with two volumes of ice cold 100% ethanol and precipitated at
-80°C overnight. The mixture was spun at 14,000rpm for 30 minutes at 4°C. Supernatant was
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discarded and pellet was washed with ice cold 70% ethanol. Residual ethanol was removed.
The RNA pellet was resuspended in RNase free water and saved at -80°C.
cDNA Generation
Then, cDNA was generated using the Fairplay III Microarray Labeling Kit (Stratagene Co.).
The RNA concentration was determined with the NanoDrop Spectrophotometer by Thermo
Fischer Scientific. 3µL of Random primers were added to 10ug of W83 and Δ0228 RNA samples.
The volume of the samples was brought up to 15µL with RNase free water. Samples were then
incubated at 70°C for 10 minutes. Samples were cooled to room temperature. 2.2µL of 10X
Affinity Script RT buffer, 1µL 20X dNTP mix, 1.5µL 0.1M DTT, 0.5µL RNAse block, 2µL Affinity
Script HCRT, and 2µL Superscript III (Invitrogen) Reverse Transcriptase were added. The
mixture was incubated overnight at 42°C. The next day, 10µL of 1N NaOH was added. The
mixture was incubated for 10 minutes at 70°C. Samples were cooled to room temperature.
10µL of 1M HCl was added to neutralize the reaction. The DNA was isolated using MinElute
PCR Purification kit from QIAGEN. During wash step, fresh TIGR was buffer was used instead of
buffer supplied by QIAGEN. The TIGR wash buffer consists of 125µL KPO4 (pH 8.5), 3.8mL MilliQ
H20, and 21.0mL of 100% ethanol per 25mL. The samples were eluted twice into 10µL of
Sodium bicarbonate (pH 9.3) making the final volume 20µL for both W83 and Δ0228. Now
cDNAs were ready for labeling.
The samples were labeled for hybridization using cyanide-labeled probes (GE Healthcare).
Wild type (W83) was labeled with Cy-3 dye and the mutant (Δ0228) with Cy-5 dye. The samples
were placed in the dark to protect the light sensitive dyes. Samples were incubated for one and
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a half hours at room temperature. Next, 5µL of 4M Hydroxylamine was added to stop the
reaction. The cDNA was isolated using the QIAGEN MinElute PCR Purification kit in the dark.
1µL of 0.1M DTT was added to each sample. Samples were saved at -20°C for pre-hybridization.
Hybridization
First, 350mL of Pre-hybridization buffer (87.5mL 20X SSC, 3.5mL 10% Sodium Dodecyl
Sulfate, 3.5g BSA powder, and 259mL MilliQ water) was prepared then filtered with a 0.22µm
Mini-Miser Filter. The buffer was pre-heated in water bath at 42°C for 30-40 minutes. The prehybridization buffer was poured over microarray slides (containing the P. gingivalis genome)
and incubated at 42°C for at least 2 hours. Then, the pre-hybridization buffer was removed and
washed with MilliQ Water by gently shaking.
Three different pre-hybridization buffers were prepared. The pre-hybridized microarray
slides were washed in each buffer. Buffer 1 consisted of 100mL of 20X SSC and 20mL 10% SDS.
Buffer 2 consisted of 100mL 20X SSC. Buffer 3 consisted of 10mL of 20X SSC and 25µL of
100mM DTT. Each buffer was brought up to a 1 Liter volume with MilliQ water and placed in a
water bath at exactly 55°C until needed. The pre-hybridized microarray slides were placed in a
clean glass container and approximately 500mL of Buffer 1 was added. The container was
wrapped up with an absorbent cloth and placed on a shaker for 15minutes at room
temperature. This step was repeated with new Buffer 1. This process was repeated with Buffer
2 (10 min. incubation) and then with Buffer 3 (5 min. incubation). After washing, the slides
were centrifuged at 1000rpm for 30 seconds to dry. If the slides contained any streaks or spots
they were rewashed.
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For microarray hybridization, both labeled W83 and labeled Δ0228 were combined (in the
dark) and purified using the QIAGEN MinElute purification kit. The DNA was then spun in a
speedvac centrifuge for approximately 10 minutes to form a DNA pellet.
A hybridization buffer was made consisting of 400µL formamide, 250µL 20X SSC, 10µL 10%
SDS, 1µL 0.1M DTT, 60µL of salmon sperm, and 339µL of MilliQ water. The hybridization buffer
was added using a 1mL syringe through a 0.45µM filter. Then, 50µL of the filtered hybridization
buffer was added to the hybridized sample containing both W83 and Δ0228. The mixture was
centrifuged for 30 seconds, vortexed, and heated at 95°C for 5 minutes. This last step was
repeated. These labeled probes were now ready to hybridize to the pre-hybridized microarray
slides.
Next, 24mm x 60mm microscope glass cover slips were gently placed of the area on the
slide containing the probes. Care was taken to make sure there were no air bubbles. 50µL of
sample containing labeled W83 and Δ0228 was added to the edge of the microarray slide. The
samples covered the entire slide by capillary action. The slides were then placed into the
hybridization chamber overnight at 42°C.
The microarray slides were then washed with 3 post-hybridization buffers. Buffer 1
contained 100mL 20X SSC, 20mL 10% SDS, and 25µL of 100mM DTT. Buffer 2 contained 100mL
20X SSC and 25µL 100mM DTT. Buffer 3 contained 10mL 20X SSC. Each buffer mixture was
brought to a final volume of 1 liter by adding MilliQ water. The buffers were preheated to 55°C.
The slides were washed in Buffer 1 and shaken until the cover slide fell off. The slides stayed in
this buffer for 10 minutes. The slides were transferred to new Buffer 1 for an incubation time
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of 10 minutes. The slides were washed in Buffer 2 for 10 minutes twice. Then, the slides were
washed in Buffer 3 for 10 minutes twice. Then the slides were centrifuged for 30 seconds to
dry the slides. At this point, the slides were ready to be analyzed by scanning.
Microarray Analysis
The Axon 4200 Scanner Program GenePix pro v6 was used to scan and analyze the
hybridization signals from the microarray slides. The slides were placed in the scanner and first
previewed to adjust wavelength and brightness conditions to optimize data. Actual data
scanning followed. The signal intensities from each probe (gene) were analyzed using
ArrayAssist software (Stratagene Co. La Jolla, CA). Each array contained 5 probes for each gene
representing the entire P. gingivalis genome.
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Figure 10. Schematic Diagram of Microarray Analysis.
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2.9.

Survival of Δ0228 Mutant Strain with Eukaryotic Cells
A survival was done with Δ0228 to analyze any changes in sensitivity to host defense

mechanisms compared to its wild type (W83). Overnight cultures of Δ0228 and W83 were
diluted to an OD660nm 0.2. The cultures were grown to an OD660nm of about 0.5 to ensure cells
were in log phase. HN4 cells were also grown in a 6 well plate to a density of 4 X 10 5 epithelial
cells/well. Both P. gingivalis cultures and the HN4 cells were washed twice with PBS. Each
bacterial strain was resuspended in their appropriate volume of antibiotic-free HN4 media.
Three wells containing HN4 cells were infected with W83 cells and 3 wells containing HN4
cells were infected with Δ0228 cells. The HN4 cells were infected at a 100:1 MOI (bacteria:host
cell ratio). This meant 4 X 107 bacteria had to be added to each appropriate well. The HN4 cells
were infected inside the anaerobic chamber at 37°C for 30 minutes. The wells were then
washed 3X with PBS media inside the anaerobic chamber to wash away the bacteria on the HN4
cell surface. A media containing 440µg/mL metronidozole and 300µg/mL gentamycin was
added to each well. These antibiotics were used to kill the bacteria left on the surface of the
HN4 cells. This was done to ensure we were left with only P. gingivalis bacteria that invaded
the HN4 cells. The cells were incubated with the antibiotics at 37°C for 60 minutes inside the
anaerobic chamber. The cells were again washed three times with PBS.
One mL of BHI supplemented with 1% saponin was added to each well. This mixture was
incubated for 15 minutes at 37°C in the anaerobic chamber. Each well was then scratched
using a cell scraper to ensure all cells were lysed. The contents of each well were added to
separate tubes of 3mL BHI media. 200µL of this sample was then diluted into a tube containing
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2mL of BHI media. Therefore, the resulting dilutions were 1:4 and 1:10. 200µL of each sample
was inoculated on to a blood agar plate totaling 12 plates (6W83/6Δ0228).
2.10.

Immunoprecipitation with 0228-HaLo Tagged Strain

A reversible cross-linking combined with immunoprecipitation was done with 0228-HaLo
strain to study RNA-protein interactions in vivo. This method is based on the chromatin
immunoprecipitation (ChIP) assay used to study DNA-protein interactions. Cross-linking with
formaldehyde allows rapid preservation of interactions between the target protein and RNA.
The cells are then lysed. A resin based ligand, the HaloLink Resin, covalently interacts with the
0228-HaLo protein and is precipitated out. The cross-links are reversed using glycine and the
RNA bound to the protein is isolated. Then, a library of RNA is generated and sequenced for
identification.
The method used for this study is based on the HaloCHIP System protocol (Promega). Both
wild type (W83) and mutant (0228-HaLo) Porphyromonas gingivalis strains are used for this
study. 30mL cultures were diluted to and OD660nm 0.2 and grown to and OD of 0.7. A 1%
concentration of formaldehyde was added to cultures and incubated at room temperature with
gentle shaking for 20 minutes. The crosslinking was stopped by adding a 125mM concentration
of glycine. Samples were then incubated for 10 minutes at room temperature. Then, cultures
were spun at 6000rpm for 10 minutes at 4°C to harvest. The supernatant was discarded and
the pellet was washed twice with ice cold PBS (pH 7.5). Pellets were stored at -80°C until
immunoprecipitation. Next, 4mL of fresh ice cold lysis buffer (50mM Tris HCl-pH7.5, 150mM
NaCl, 0.1% Sodium deoxycholate, 1% Triton X-100) was added and incubated on ice for 5
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minutes. The crosslinked complexes are then sonicated to help solubilize them using a
sonicator and spun at 14000g for 5 minutes at 4°C. Supernatant is collected.
Next, the HaloLink Resin is prepared according to company’s protocol (Promega). Then,
500µL of HaloLink Resin is centrifuged at 800g for 2 minutes and supernatant is discarded.
Immediately, 1mL of resin equilibration buffer (1X TE buffer-pH 8.0, 0.1% IGEPAL) is added to
the resin and mixed by inverting several times. The sample is then centrifuged at 800g for 2
minutes and supernatant is removed. This process is repeated two more times. It is very
important to keep the beads moist until sonicated samples are added.
The supernatant from sonication spin is collected and added to the equilibrated
HaloLink Resin. Samples are incubated for 3hrs with shaking at room temperature. After
incubation, samples are spun at 800g for 2 minutes and supernatant is removed. Then, 5mL of
lysis buffer is added to the resin, mixed, and spun again at 800g. Supernatant is removed and
nuclease free water is added, centrifuged, and removed, twice. 1mL of high salt was buffer
(50mM Tris HCl-pH7.5, 700mM NaCl, 1% Triton X-100, 0.1% Sodium deoxycholate, and 5mM
EDTA) is added, mixed, and incubated for 5 minutes. Samples are then centrifuged and
supernatant is discarded. Next, 1mL of LiCl wash buffer (100mM Tris HCl-pH 8.0, 500mM LiCl,
1% IGEPAL, and 1% Sodium deoxycholate) is added, mixed, centrifuged, and supernatant
discarded. A 1mL sample of nuclease free water is added, mixed, centrifuged, and supernatant
discarded. Then, 1mL of nuclease free water is added, mixed, incubated for 5 minutes,
centrifuged, and supernatant discarded. Next, 500µL of reversal buffer (10mM Tris HCl-pH 8.0,
1mm EDTA, and 300mM NaCl) is added, mixed by pipetting, and incubated for 45 minutes at
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70°C to reverse the cross-linking done by formaldehyde. After spinning, the supernatant is
collected followed by RNA isolation using RNA isolation protocol previously described. Pellet of
RNA is suspended in 10µL of RNase free water followed by a DNase treatment from Ambion Inc.
Next, a RNA library is generated using ScriptSeq mRNA-Seq Library Preparation kit according
to manufacturer’s directions (Epicentre Biotechnologies, Madison, WI). Both a 1µL StarScript
Reverse Transcriptase Buffer and 1µL of cDNA Synthesis Primer is added to the 10µL RNA
sample. Mixture was incubated at 85°C for five minutes and placed on ice in order to fragment
the RNA. Next, cDNA was generated by adding the cDNA synthesis master mix (1.5µL StarScript
Reverse Transcriptase Buffer, 1µL dNTP PreMix, 0.5µL RiboGuard RNase inhibitor, and 0.5µL
StarScript Reverse Transcriptase to each sample. Samples were placed in the thermocycler at
25°C for 5 minutes, 45°C for 20 minutes, then 1µL of Finishing Solution was added and samples
were incubated at 37°C for 10 minutes, and 95°C for 3 minutes. Samples were then placed on
ice until the 3’ tagging of cDNA. Terminal Tagging Master Mix (1µ Terminal Tagging Oligo, 0.5µL
DTT, and 0.5µL DNA Polymerase) was added to each sample and mixed. Samples were heated
at 37°C for 15 minutes, 95° for 3 minutes, then 1µL of Finishing Solution was added and
samples were incubated at 37°C for 10 minutes, and 95°C for 3 minutes before being placed on
ice. The di-tagged cDNA was then purified using the MinElut PCR Purification Kit (QIAGEN) and
eluted into 20µL of EB buffer. Next, the samples are amplified by PCR. PCR mix (4.5µL nuclease
free water, 25µL FailSafe PCR PreMix E, 1µL Forward Primer, 1µL RNA-Seq Barcode Primer, and
0.5µL FailSafe PCR Enzyme) is added to cDNA and placed in the thermocycler for 12 cycles.
Excess PCR primers are removed by adding 1µL of Exonuclease I to each reaction and incubated
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at 37°C for 15 minutes. Reactions are again purified using the QIAGEN MinElute PCR
Purification Kit and sent in for sequencing.
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Figure 11. Broad Overview of Immunoprecipitation Using 0228-HaLo. This study was done
to see if the PG0228 protein (1) binds to RNA and (2) the identities of these bound RNAs.
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2.11

Bioinformatics
The amino acid sequence of PG0228 (PG0253, according to NCBI and TIGR designations)

was taken from ORALGEN and inserted into BLAST protein sequence alignment program
(http://blast.ncbi.nlm.nih.gov/Blast.cgi)[3]. Then, the 152 amino acids sequence was then
searched for similarities against the NCBI database. A taxonomy report was established by
using the Taxonomy Report tool within BLAST. Also, a tree was established by using the
Distance Tree of Results tool within BLAST.
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Chapter 3: RESULTS
3.1.

Sequence Alignment with PG0228
According to BLAST protein sequence alignment[3], PG0228 contains a conserved Sm

like family domain and it partially aligns with DUF150 (Figure 1seq.). Details about the Sm like
family can be found within the introduction under Sm Family of RNA-Associated Proteins.
DUF150 is designated as uncharacterized BCR, within YhbC family COG0779. The taxonomy
report shows significant homology between PG0228 and proteins within Bacteroidetes phylum
(Figure 1seq.). Most proteins within this group are hypothetical proteins and therefore their
function has not been determined. Sequence alignment also exists with a ribosome maturation
factor RimP for 7 species. A tree view of sequence alignment was also established showing the
distance between the species encoding the similar protein within the CFB group of bacteria
(Figure 2seq.). There was also alignment to an unnamed protein product and sea anemones.

(a)
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(b)

Figure 1seq. (a) Amino acid alignment of PG0228 (152aa) showing its conserved domains
with the Sm like family. (b) Taxonomy BLAST report of PG0228 protein sequence.
Species with similar protein sequences are listed according to NCBI.

54

Figure 2seq. Amino Acid Alignment of PG0228 in Distance Tree Formation.
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3.2.

Generation of Δ0228 Mutant Strain
The Δ0228 mutant strain contains a deletion of gene PG0228 (LANL gene ID) along with

insert of ermF cassette marker (1Kb). ErmF is an antibiotic resistance gene cassette marker for
erythromycin and clindamycin[27]. A PCR amplification of genomic P. gingivalis fragments was
done. Three separate PCRs were set up to amplify each flanking DNA fragment. Samples were
then run on a 1% agarose gel to confirm fragment length using a 1kb Plus DNA ladder (Figure
12). Mut1 amplification shows a length of 250bp and Mut2 amplification has a length of 750bp.
pVA2198, containing ermF, was used as a template to amplify the ermF clindamycin resistance
cassette. The ermF cassette equaled a length of 1.1kb on the 1% agarose gel. Next, the
purified flanking DNA fragments from this general PCR were annealed together through fusion
PCR techniques using Mut1, ermF, and Mut2 as a DNA template. The purified DNA construct
was run on a 1% agarose gel resulting in a length of 2.1kb, therefore indicating the three
individual fragments annealed together in the fusion PCR.
The desired PCR fragment was cloned into the pCR2.1-TOPO vector (Invitrogen) that
carries both an ampicillin (bases 2129-2989) and kanamycin (bases 1317-2111) antibiotic
resistance-encoding gene. Between the M13 forward primer (bases 389-404) and reverse
primer (bases 205-221) the desired PCR fusion product was inserted. It is also important to
note the 3.9kb vector contained the lacZ gene. The ligation mixture was then used to introduce
the desired PCR fragment into TOP 10 E. coli chemically competent cells. After the
transformation, the mixture was spread on an LB plate supplemented with X-gal and kanamycin
to grow overnight. Transformed E. coli containing plasmid with kanamycin resistance gene
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were capable of growing on the supplemented LB plate despite the presence of the antibiotic.
Both blue and white colonies appeared on the plate after the incubation period. Only white
colonies were candidates for successful ligations. E. coli containing a functional β-galactosidase
enzyme metabolizes the galactose sugar (X-gal) forming an intermediate which is
spontatneously oxidized to a bright blue pigment. White colonies contain vector with foreign
DNA inserted within the lacZ gene which disrupts the β-galactosidase enzyme, indicated by
their lack of bright blue pigment.
Plasmids were isolated from 3 white E. coli colonies (designated A, B, and C) and
digested with the EcoRI enzyme. EcoRI restriction enzyme sites were located on both sides of
PCR fragment insertion and will result in two DNA fragments at 3.9kb and 2.1kb if insertion is
correct. Digestions of all three candidates were run on an agarose gel (Figure 13). Plasmid
digestion of colony A shows 4 fragments on the gel equaling 1.4kb, 2.1kb, 3.9kb, and
approximately 6kb. Colonies in lane B and C each show one fragment on the agarose gel,
equaling a length of 3.9kb. 3.9kb is the length of the TOPO vector alone, therefore B and C do
not contain the insert. A, however, contains fragments 2.1kb and 3.9kb in length, therefore
further screening tests were done. Sample A and W83 genomic DNA were amplified by PCR
with the original MutF1 and MutR2 primers (Figure 14). W83 genomic DNA was used as a
control which resulted in a length of 1.5kb which is the length predicted of wild type. An
agarose gel confirmed the DNA fragment insert equals a length of 2.1kb so the isolated
construct was sent in for plasmid sequencing. The isolated pCR2.1-TOPO vector containing the
PCR fusion insert was sequenced using standard M13 forward and reverse primers by DNA Core

57

(MCV-VCU Nucleic Acids Research Facilities, Richmond, VA). Each result contained the correct
ordered sequence of Mut1-ermF-Mut2.
PCR fusion product was electroporated into P. gingivalis to obtain the Δ0228 mutant
strain. After an incubation of 7 days inside the anaerobic chamber, 8 P. gingivalis colonies were
selected for mutant selection and plated onto both clindamycin and blood agar plates.
Genomic DNA was isolated from each sample and mutant DNA was amplified with the original
MutF1 and MutR2 primers (Figure 15). Wild type W83 genomic DNA was used as a control to
select for mutants. Agarose gel confirmed samples 1, 2, 3, 4, 5, 7, and 8 were identical with a
band length of 2.1kb and most likely Δ0228 mutants. Genomic DNA amplification of wild type
resulted in a length of 1.5kb. Genomic DNA from sample 6 did not appear on the agarose gel.
PCR products from mutants 1, 3, 5, and 8 were confirmed by sequencing done by DNA Core
(MCV-VCU Nucleic Acids Research Facilities, Richmond, VA). Each contained the correct
ordered sequence of Mut1-ermF-Mut2. The sequence of the determined genomic DNA can be
found in Appendix.
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Figure 12. Generation of Δ0228 Mutant DNA Fragment. (a) General PCR to amplify each
flanking DNA fragment. Mut1 (A) was amplified using primers Mut1F/Mut1R. Mut2 (B) was
amplified using primers Mut2F/Mut2R, and ermF (C) , for mutant selection, was amplified
using primers ErmF1/ErmR2. P. gingivalis genomic DNA was used as a template for Mut1 and
Mut2. Plasmid pV2198 was used as a template for ermF. (b) These purified DNA segments
were annealed together by a second round of PCR. Mut1, ermF, and Mut2 were used as
templates in a Fusion PCR and run on a 1% agarose gel for confirmation.
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Figure 13. Plasmid screening with EcoRI digestion. Plasmids were isolated
from 3 E. coli colonies grown on LB plates supplemented with kanamycin
and x-gal. A, B, C plasmids isolated from 3 colonies, pCR2.1 TOPO TA +
insert screening. B and C show one band indicating vector contains no
insert. Only A contains the DNA insert (2.1kb) band and vector band
(3.9kb). IKb marker is included in lane on the left side of the gel, the sizes of
corresponding bands are shown in image of 1Kb ladder.
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Figure 14. PCR amplification to check for mutant DNA fragment. Isolated plasmids (B, C,
D) and P. gingivalis genomic DNA (A) were amplified using original fusion primers MutF1
and MutR2 and run on an agarose gel. The isolated plasmids (B, C, D) contain fragments
equaling around 2.1kb while the W83 control (A) contains a fragment of 1.5kb in length
predicted of wild type. Plasmid constructs were therefore sent in for sequencing.
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Figure 15. Δ0228 Mutant Selection by Amplification of Genomic DNA. Verified mutant
DNA fragment was electroporated into Porphyromonas gingivalis to obtain Δ0228
mutant strain. Eight P. gingivalis colonies were selected for mutant screening. Lanes
labelled “a” are concentrated samples. Lanes labelled “b” contain a lower concentration
of 50ng/µL. Genomic DNA was isolated from each sample and amplified with the
original primers MutF1 and MutR2. W83 genomic DNA (P.g) was used as a control to
select for mutants. Samples 1, 2, 3, 4, 5, 7, and 8 are potential mutants because primers
amplified the predicted 2.1kb fragment. Identical primers amplified 1.5kb fragments in
the P.g control. Samples 1,3, 5, and 8 were sent for sequencing.
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3.3.

Generation of 0228-HaLo tagged Porphyromonas gingivalis Strain
The 0228-HaLo tagged strain was created in order to show if protein PG0228 indeed

binds to RNA. The strain does not have any genetic deletions and behaves like wild type W83
but includes an additional HaLoTag downstream of PG0228 and ermF for mutant selection. The
primers CF2/CR2 were used to amplify PG0228 from W83 genomic DNA. An agarose gel
confirmed the band length of the amplification is approximately 500bp (Figure 16). For cloning
purposes, PG0228 and ermF-ermAM were inserted into our desired vector, pFC20K (HaLoTag 7)
T7 SP6 Flexi Vector. The HaLoTag vector measures a length of 4417 base pairs, includes a
region for PCR insertion between nucleotides 71-78, and contains an open reading frame for
HaLoTag (507-1397). Specific primers were selected based on manufacturer’s suggestions
(Promega, Madison, WI). Specific primers for PG0228 were intended to produce 3’ overhangs
for easy insertion between SgfI and EcoICRI restriction sites (Figure 16). Cutting the vector with
SgfI and EcoICRI excises the lethal barnase gene from the vector, thus allowing propagation in
E. coli. The 2.1kb ermF-ermAM was inserted with manufacturer suggested restriction enzymes
(Promega, Madison, WI) EcoRI and XbaI downstream of tagging region between nucleotides
1398-1509. Enzymes were compared and chosen based on specificity of digestion. A list of
acceptable enzymes needed to cut the Halo vector once but not cut our gene of interest
(http://tools.neb.com/NEBcutter2/index.php). The plasmid vectors, HaLoTag and pV2198,
which contains ermF-ermAM, were digested with EcoRI and XbaI for ermF-ermAM insertion
(Figure 17).
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The HaLoTag vector containing PG0228 and ermF-ermAM was introduced to One Shot
TOP10 chemically competent E. coli. Eight positive white colonies went through additional
screening by PCR using primers FP-Erm/RP-Erm. Figure 18 includes an agarose gel containing
the PCR products from the 8 colonies. Samples 1, 2, 3, and 4 show bands 2.1kb in length
indicating these pFC20K plasmids include the 2.1kb ermF-ermAM insert.
The mutant construct containing PG0228, HaloTag, and ermF was amplified by PCR
using primers CF2/ermR2. It is important to note the ermR2 primer amplifies only the first 1kb
of ermF-ermAM cassette containing clindamycin resistance only. DNA agarose gel analysis of
amplification shows band length of 2.5kb (Figure 19). This length would agree with our
prediction and therefore we then proceeded with the addition of the 5’ segment of PG0228’s
downstream gene, nusA. The 5’ segment (600bp) of nusA was added to ensure a double crossover into W83 genomic DNA. Figure 3.8 shows the amplification of the nusA segment from
W83 genomic DNA using primers ExtF/ExtR. In order to anneal the mutant construct with the
nusA extension, fusion PCR methods were used. An agarose gel (Figure 20) revealed a band at
3kb indicating the 2 flanking fragments annealed together.
The desired PCR fragment was cloned into the pCR2.1-TOPO vector and transformed
into One Shot TOP10 chemically competent E. coli. Plasmids were isolated from 7 white
colonies and verified by sequencing done by Retrogen Inc. (San Diego, CA). Each contained the
correct ordered sequence of PG0228-HaLo-ermF-nusA. The sequence of the determined
genomic DNA can be found in Appendix.
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Electroporation into P. gingivalis was done to obtain the 0228-tagged fusion mutant
strain. After an incubation of 7 days inside the anaerobic chamber, 4 P. gingivalis colonies were
selected for mutant selection and plated onto both clindamycin and blood agar plates.
Genomic DNA was isolated from each sample and mutant DNA was amplified with FP-Erm/ExtR
primers (Figure 21). Wild type W83 genomic DNA and the sequenced plasmid were used as a
control to select for mutants. Agarose gel revealed both the amplified sequenced plasmid,
acting as the positive control, and mutant genomic DNA showed bands at 1.6kb, confirming the
generation of the desired 0228-tagged fusion mutant strain. No amplification was found using
FP-Erm/ExtR primers on wild type W83.
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Figure 16. Amplification of PG0228. Agarose gel representing the amplification of the
456bp PG0228 (Lanes A-F) using specific primers CF2 and CR2 for direct HaLoTag plasmid
insertion. The fragment is then inserted into the desired 4.4kb vector, pFC20K (HaLoTag
7) T7 SP6 Flexi Vector. to add the specific 1kb C-terminal tag to the protein. PG0228 is
inserted into the HaLoTag vector between the SgfI and EcoICRI restriction sites.
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Figure 17. Digestion of pFC20K and pV2198 with EcoRI and XbaI. Undigested pFC20K
(HaLoTag 7) T7 SP6 Flexi Vector is found in Lane A. Both pFC20K (B) and PV2198(C-G)
are digested with EcoRI and XbaI in order to insert the 2.1kb ermF-ermAM into the
pFC20K vector. PV2198 is digested into 3 fragments . The bottom fragment contains
ermF-ermAM. The 2.1kb ermF-ermAM is inserted into pFC20K downstream of tagging
regions between nucleotides 1398-1509.
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Figure 18. Transformation Colony Screening. Agarose gel confirming the insertion of
ermF-ermAM into vector by PCR using primers FP-Erm/RP-Erm. pFC20K plasmids were
isolated from E. coli colonies grown on LB plates supplemented with kanamycin and xgal. Four colonies(A-D) show the transformation of DNA construct including ermFermAM 2.1kb insert. Lane I contains pV2198 also amplified with primers FP-Erm/RPErm as a control.
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Figure 19. Amplification of the Mutant Construct Containing PG0228, HaLoTag, and ermF
(A) and 5’nusA Extension (B). The mutant construct containing PG0228, HaLoTag, and ermF
(2.5kb) was amplified using primers CF2/ermR2. The nusA extension (600bp) was amplified
using primers ExtF/ExtR. Only ermF was amplified from ermF-ermAM cassette because
fusion PCR methods tend to have a higher incidence of nonspecific amplification with longer
DNA fragments.
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Figure 20. Annealing 0228-HaLo Construct to nusA Extension Using Fusion PCR
methods. An agarose gel shows the amplification of a 3kb band using the primers
CF/ExtR. The 5’ segment (600bp) of nusA was added to ensure a double cross-over
into W83 genomic DNA. Individually, the mutant construct containing PG0228,
HaLoTag, and ermF equals a length of 2.5kb, while the nusA extension measures a
length of 600 base pairs. When annealed together, the final product, 0228-HaLo DNA
fragment, measures a length of around 3.1kb. This 0228-HaLo DNA fragment is then
electroporated into P. gingivalis to obtain the 0228-HaLo strain.
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Figure 21. PCR Confirmation of 0228-HaLo Strain. Electroporation into P. gingivalis was
done to obtain the 0228-HaLo strain. P. gingivalis colonies were selected for mutant
selection and plated onto both clindamycin and blood agar plates and their genomic DNA
isolated. 0228-HaLo strain (A), pCR2.1-TOPO vector containing 0228-HaLo mutant DNA
fragment (B), and W83 genomic DNA were amplified using primers FP-Erm/ExtR. Wild type
W83 and sequenced plasmid were used as a control to select for mutants. Both the mutant
strain (A) and plasmid (B) contain the 1.5kb amplification of ermF-5’ nusA, however, no
amplification was found using FP-Erm/ExtR primers on W83 because W83 does not contain
ermF.
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3.4.

Evaluation of Δ0228 Growth Compared to Wild Type W83
A growth study was done to assess the growth of the Δ0228 mutant strain compared to

the W83 wild type. Overnight cultures of both strains were diluted to an optical density of 0.1
in BHI + hemin media. Both W83 and Δ0228 were grown in triplicates. The growth was
measured for 24hrs in 4hr increments (8hrs for the 16-24hr time block).
Table 2 contains OD recordings for WT and Δ0228. Six time points were taken from
both triplicates equaling 36 data points. There were no optical densities taken at the 20hr
incubation time point. According to these data, the growth rate of Δ0228 strain is comparable
to W83 for the first 8-10 hrs of incubation which is the log phase of bacterial growth for these
strains. The mutant bacteria, however, enters stationary phase, indicated by the loss of slope
on the graph, at an earlier time point than W83. The overall density of the mutant strain peaks
at 12hrs with an OD of 0.831 average for the triplicate while W83 has not yet shown entrance
into stationary phase at 24hrs. At 24hrs after dilution, the average optical density of Δ0228
strain is 0.775. The average optical density of W83 is higher at 1.184 24hrs after dilution. The
growth study was repeated with data measured in 2hr and 5hr increments. The data from both
studies mirror data points given in this study with 4hr increments and thus confirms that the
observation is biologically consistent.
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Table 2.
(a) Optical Density of Δ0228 Compared to W83 at Specific Incubation Periods.
0hrs

4hrs

8hrs

12hrs

16hrs

20hrs

24hrs

W83 (1)

0.098

0.32

0.561

1.007

1.158

N/A

1.247

W83 (2)

0.095

0.321

0.552

0.983

1.149

N/A

1.185

W83 (3)

0.133

0.331

0.551

0.964

1.161

N/A

1.121

Δ0228 (1)

0.135

0.517

0.719

0.825

0.821

N/A

0.768

Δ0228 (2)

0.131

0.519

0.695

0.844

0.823

N/A

0.791

Δ0228 (3)

0.108

0.489

0.701

0.824

0.822

N/A

0.766

(b) Average Optical Density of Triplicate.
W83

0.109

0.324

0.555

0.985

1.156

N/A

1.184

Δ0228

0.125

0.508

0.705

0.831

0.822

N/A

0.775
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Figure 22. Growth Rate of Δ0228 Mutant Strain. This figure reveals the growth
rate of the Δ0228 mutant strain compared to its wild type. The mutant strain lacks
PG0228. Both strains are grown in identical conditions and at the same time.
Optical densities were taken by a spectrophotometer at a wavelength of 660nm at
4hr time points. The strains were observed for 24hrs for final density
measurements. (a) Strains were grown in triplicates and optical densities (b) and
their averages were recorded. Optical densities of triplicates were then plotted out
on a graph for better visual representation. No recordings were taken at 20hrs
post dilution.
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3.5.

Differential Gene Expression Determined Using Microarray Analysis
The Δ0228 strain was further studied for differential gene expression using microarray

analysis. To gain a better insight into whether PG0228 plays a role in gene regulation,
expression profiles of the mutant were compared to wild type. Both W83 and Δ0228 were
grown to an OD660 of 0.5 under the same conditions and harvested simultaneously. Overnight
cultures were diluted to an OD660 measurement of 0.2 and allowed to grow to an OD
measurement of 0.5. Final OD values of both strains were within 0.07 of each other before
harvesting. Previous growth studies revealed the Δ0228 strain grows at the same rate as W83
until the mutant reaches early stationary phase around an OD of 0.7. Thus, both strains were
used at their logarithmic phase of growth for microarray analysis. Also, their growth rates were
the same thus excluding any effects of growth rate on the array results.
Differentially labeled cDNA from W83 (635nm) and Δ0228 (532nm) were combined and
used to hybridize to glass slides containing probes for all genes present on the genome of P.
gingivalis W83 strain. The quantity of each hybridized label to gene probe was detected with
an Axon4200 scanner. Data from signal detection was processed for statistical significance
using ArrayAssist software (Stratagene).
Each gene present on the W83 genome had 5 probes on the glass slide, thus 5
measurements were made for each P. gingivalis gene. Statistical analysis was taken from 4
probes and averaged. 19 genes were found significantly upregulated (Table 3), and 60 genes
were found significantly downregulated (Table 4) in the Δ0228 mutant strain compared to W83.
Each gene selected had an average fold change of close to 2 or higher (1.6 < ratio 635/532 <
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0.56). Only genes with 4 consistent upregulated or downregulated ratios were included and
averaged.
Of the 19 upregulated genes detected by microarray, 16 had an average fold change of
greater than 2. 3 of these genes, PG007, PG1133, PG1185 are hypothetical proteins and
therefore their function is unknown. Other upregulated genes include those encoding proteins
involved in metabolism including PG0195 (rubrerythrin), PG1421, PG1813, and PG1190
(glycerate dehydrogenase): all involved in electron transport during oxidative stress.
Of the 60 downregulated genes detected by microarray, 50 had an average fold change
of greater than 2. Downregulated PG1294 (ferrous iron transport protein B), PG1551 (hmuY
protein), and PG1552 (TonB-dependent receptor hmuR) are all involved in iron uptake. Fifteen
of these detected downregulated targets include enzymes and 28 hypothetical proteins.
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Table 3. Upregulated Genes Detected in Δ0228 Strain.

Primary
Target

Common Name of Primary Target

Gene
Symbol

Ratio (635/532)

PG0007

hypothetical protein

0.49

PG0079

abortive Infection protein, putative

0.44

PG0152

carboxynorspermidine decarboxylase

PG0195

rubrerythrin

0.34

PG0548

pyruvate ferredoxin/flavodoxin oxidoreductase family
protein

0.47

PG0651

HDIG domain-containing protein

0.44

PG0682

ABC transporter, permease protein, putative

0.32

PG1048

N-acetylmuramoyl-L-alanine amidase

0.45

PG1049

ABC transporter, permease protein, putative

0.33

PG1133

Hypothetical protein

0.47

PG1185

Hypothetical protein

0.46

PG1190

glycerate dehydrogenase

hprA

0.48

PG1239

3-oxoacyl-(acyl-carrier-protein) reductase

fabG

0.37

PG1421

ferredoxin, 4Fe-4S

0.14

PG1687

HIT family protein

0.40

PG1688

transcription elongation factor GreA

greA

0.35

PG1765

acyl carrier protein

acpP

0.53

PG1813

ferredoxin, 4Fe-4S

PG1956

4-hydroxybutyrate CoA-transferase

nspC

0.49

0.56
abfT-2

0.51
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Table 4. Downgulated genes detected in Δ0228 strain.
Primary
Target

Common Name of Primary Target

Gene
Symbol

Ratio (635/532)

PG0253

Hypothetical protein

5.06

PG0258

ABC transporter, ATP-binding protein

2.32

PG0437

BexD/CtrA/VexA family polysaccharide export
protein

2.22

PG0451

CBS domain-containing protein

2.01

PG0495

Hypothetical protein

3.34

PG0613

Hypothetical protein

2.59

PG0768

Hypothetical protein

4.25

PG0805

Prolipoprotein diacylglyceryl transferase

PG0838

Integrase

2.38

PG0854

Hypothetical protein

11.57

PG0855

Hypothetical protein

3.06

PG0933

Elongation factor G

2.66

PG0972

Hypothetical protein

2.91

PG0987

Hypothetical protein

1.98

PG1021

Hypothetical protein

1.99

PG1029

Hypothetical protein

2.52

PG1036

Excinuclease ABC, A subunit

PG1040

Transcriptional regulator, putative

PG1077

Electron transfer flavoprotein, beta subunit

PG1107

Hypothetical protein

4.45

PG1110

Hypothetical protein

1.80

igt

uvrA-1

2.83

2.45
8.03

etfB-2

1.92
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Primary
Target

Common Name of Primary Target

Gene
Symbol

Ratio (635/532)

PG1128

Exodeoxyribonuclease VII large subunit

xseA

3.05

PG1138

Pigmentation and extracellular proteinase
regulator

porR

1.60

PG1155

ADP-heptose--LPS heptosyltransferase, putative

3.09

PG1175

ABC transporter, ATP-binding protein, putative

1.92

PG1178

Hypothetical protein

7.24

PG1179

Hypothetical protein

2.27

PG1180

Hypothetical protein

5.02

PG1181

TetR family transcriptional regulator

2.45

PG1184

Alginate O-acetyltransferase, putative

1.88

PG1229

Hypothetical protein

4.07

PG1230

Hypothetical protein

2.81

PG1294

Ferrous iron transport protein B

PG1395

Rod shape-determining protein MreC

11.22

PG1473

Conjugative transposon protein TraQ

1.97

PG1484

Hypothetical protein

2.24

PG1513

Phosphoribosyltransferase,
putative/phosphoglycerate mutase family protein

1.89

PG1525

Isochorismate synthase, putative

2.49

PG1528

Hypothetical protein

4.26

PG1551

HmuY protein

feoB-2

hmuY

2.12

7.29
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Primary
Target

Common Name of Primary Target

Gene
Symbol

Ratio (635/532)

PG1552

TonB-dependent receptor HmuR

hmuR

7.13

PG1554

Hypothetical protein

4.12

PG1570

Rhodanese-like domain-containing protein

11.26

PG1662

Hypothetical protein

2.51

PG1666

RND family efflux transporter MFP subunit

1.82

PG1679

Hypothetical protein

2.97

PG1733

Hypothetical protein

3.78

PG1814

DNA primase

PG1842

Acetyltransferase

2.47

PG1858

Flavodoxin FldA

9.15

PG1892

Hypothetical protein

2.19

PG2043

Hypothetical protein

2.51

PG2061

Dihydrofolate reductase

PG2070

Hypothetical protein

2.55

PG2071

Hypothetical protein

2.72

PG2081

Biotin synthetase

PG2102

Immunoreactive 61 kDa antigen PG91

2.01

PG2103

Hypothetical protein

2.08

PG2171

D-isomer specific 2-hydroxyacid dehydrogenase
family protein

3.45

PG2189

Aspartate kinase

dnaG

folA

bioB

lysC

2.17

8.10

6.96

2.18
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Table 5. Transcription Profile of nusA, locus located downstream of PG0228.

Primary
Target

Common Name of Primary Target

Gene
Symbol

PG0229

Transcription elongation factor nusA

nusA

Ratio (635/532)

P#

1

Transcription elongation factor

nusA

0.87

P#

2

Transcription elongation factor

nusA

1.02

P#

3

Transcription elongation factor

nusA

1.02

P#

4

Transcription elongation factor

nusA

1.03

Transcription elongation factor

nusA

0.98

Average
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Table 6. Transcription Profile of LuxR transcriptional regulator.

Primary
Target

Common Name of Primary Target

Gene
Symbol

PG1237

LuxR Family Transcriptional Regulator

luxR

Ratio (635/532)

P#

1

LuxR Family Transcriptional Regulator

luxR

0.73

P#

2

LuxR Family Transcriptional Regulator

luxR

1.09

P#

3

LuxR Family Transcriptional Regulator

luxR

1.02

P#

4

LuxR Family Transcriptinoal Regulator

luxR

1.12

LuxR Family Transcriptional Regulator

luxR

0.99

Average
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Table 7. Transcription Profile of luxS

Primary
Target

Common Name of Primary Target

Gene
Symbol

Ratio (635/532)

PG0498

Ribosylhomocysteinase

luxS

P#

1

Ribosylhomocysteinase

luxS

1.25

P#

2

Ribosylhomocysteinase

luxS

1.34

P#

3

Ribosylhomocysteinase

luxS

1.35

P#

4

Ribosylhomocysteinase

luxS

1.35

Ribosylhomocysteinase

luxS

1.32

Average
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3.6.

Analysis of Δ0228’s Ability to Survive with Host Cells
A survival was done with Δ0228 to analyze its ability to handle changes in environment.

In order to expose the strains to host environmental conditions, bacteria were introduced to
HN4 epithelial cells at a 100:1 MOI. Δ0228 and W83 cultures were grown to an OD660nm of
about 0.5 to ensure cells were in log phase (Figure 23). It is important to note there has been
no evidence of changes in epithelial invasion rate between the two strains. Thus, the number
of invading bacteria into the HN4 cells is theoretically identical. Studies have shown a small
percentage of W83 bacteria will invade the HN4 cell if introduced. 4 X 105 HN4 cells are
infected at a 100:1 MOI in triplicates, resulting in 6 HN4 wells. In order to evaluate only the
bacteria inside the epithelial cells, the HN4 cells were incubated with an antibiotic to kill
extracellular bacteria. Therefore, only bacteria inside the HN4 cells are analyzed. After the 30
minute infection, the HN4 cells are lysed. The lysate containing the invading bacteria is plated
at a 1:4 and 1:10 dilution on BHI + He plates. Seven-to-ten days later, viable colonies are
counted. Table 8 represents the number of colonies of each strain after incubation period.
The number of resulting Δ0228 colonies after incubation period ranged from 0-6 from
the 1:4 dilutions, and ranged between 0-2 from the 1:10 dilutions. The number of resulting
W83 colonies was significantly higher ranging from 4-94 from the 1:4 dilutions and 0-35 from
the 1:10 dilutions. 2.3 (Δ0228) and 40.7 (W83) are the average number of colonies appearing
on the BHI + hemin plates from the 1:4 dilutions (Figure 25).
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Figure 23. Survival Schematic. This figure demonstrates a simplistic protocol of the
survival study done with HN4 cells.
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Figure 24. Photo of Δ0228 and W83 Colonies for Survival Study. A survival study
was completed to analyze any changes in sensitivity to host defense mechanisms
compared to W83. Photo represents the differences in viability between the two
strains post epithelial invasion. The top photo is the Δ0228 strain seven days after
invasion. The bottom photo is the W83 strain seven days after invasion .
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Strain

Dilution

# of Colonies

Δ0228a

1:4

1

Δ0228b

1:4

6

Δ0228c

1:4

0

Δ0228a

1:10

0

Δ0228b

1:10

2

Δ0228c

1:10

0

W83a

1:4

24

W83b

1:4

94

W83c

1:4

4

W83a

1:10

2

W83b

1:10

35

W83c

1:10

0

Strain

Dilution

Range

Δ0228

1:4

0-6

Average # of
Colonies
2.3

W83

1:4

4-94

40.7

Δ0228

1:10

0-2

0.67

W83

1:10

0-35

12.3

Table 8. The number of colonies found on the blood agar plates after HN4 invasion. 4 X
105 HN4 cells are infected at a 100:1 MOI in triplicates. Invading bacteria is plated at a 1:4
and 1:10 dilution on BHI + He plates. Seven-to-ten days later, viable colonies are counted.
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45
40.7
40
35
30
25

Dilution 1:4

20

Dilution 1:10
15

12.3

10
5

2.3
0.67

0
Δ0228

W83

Figure 25. Survival Data. Average number of colonies appearing on the BHI +
hemin plates from both 1:10 and 1:4 dilutions from Survival
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Chapter 4: DISCUSSION
4.1.

Δ0228 Strain
Several steps were completed to ensure that Δ0228 was engineered correctly. General

PCR methods were first used to produce individual desired fragments. By amplifying specific
segments of W83 genomic DNA surrounding our gene of interest, we were able to manipulate
the sequencing within the gene. This amplified DNA surrounding the gene of interest still
allowed for easy integration back into the W83 genome, but it gives the added advantage of
deleting or adding fragments between the crossover segments.
Flanking DNA fragments were amplified using primers Mut1F and Mut1R and with
Mut2F and Mut2R. Mut1R and Mut2F, for instance, were designed so that the amplification
produces fragments with tails that have the same identity as the ends of the ermF cassette.
The Mut1 and Mut2 fragments and the pre-amplified ermF cassette are then annealed together
through fusion PCR by Mut1F and Mut2R primers. Numerous fusion PCR attempts were made
before our fragment was amplified. Because the final length of our fragment was over 2 kb and
we were attempting to anneal 3 segments together, troubleshooting with different annealing
temperatures, extension times, and enzyme concentrations were needed until one combination
amplified the DNA fragment.
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It is important to verify each step of this process to make sure the DNA is indeed being
amplified, it is the right length, and finally, it is the desired fragment. Figure 12 (a) confirms the
individual DNA fragments are the correct length and (b) confirms the fusion PCR amplified a
fragment that matches our desired length. Although it is highly unlikely these specific primers
amplified a different fragment coincidently the exact same length, the fragment was sequenced
to confirm correct sequencing.
Before the fragment was sequenced, it was cloned into the TOPO-TA Vector. This was
done because the DNA fragment is significantly more stable when ligated to a vector for
storage. Once the DNA fragment was sequenced it still needed to be integrated into the W83
genome in order to generate a mutant strain. Generating a mutant strain allows observation of
many factors, including changes in phenotype and gene expression, not possible to see by
looking at the fragment at the molecular level alone. The fragment was therefore
electroporated into P. gingivalis W83 for transformation. Mutant screening was verified by
PCR amplification and genomic DNA sequencing. Screening with the original Mut1F and Mut2R
primers (Figure 15) on the potential mutants and W83 will produce a longer fragment in mutant
by 0.5kb if integration has occurred. Even though the mutant fragment has the 456bp PG0228
removed, it has the 1kb ermF antibiotic resistance cassette inserted in its place. Therefore, the
addition of the cassette in the mutant produces a 2.1kb fragment while W83 produces a 1.6kb
fragment, as demonstrated by the agarose gel on Figures 14 and 15.
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4.2.

Differential Gene Expression
Microarray analysis establishes differential gene expression between Δ0228 and W83

strains, demonstrating that PG0228 plays a significant role in gene regulation in Porphyromonas
gingivalis. It is uncertain to say, however, what the mechanism of this regulation is. Of the
2,227 loci analyzed, close to 5% of genes were found to have a fold change of near 2 or above in
abundance of RNA transcripts (1.6 < ratio 635/532 < 0.56). Our array has 5 probes which serve
as technical replicates and are used to confirm accuracy of array hybridization. For our work,
only genes with 4 consistently detected regulated ratios were included and averaged. More
than 100 additional genes showed an average fold change of 2 or higher from 3 of the 5 probes,
but are not included in the table and their differential expression will need to be confirmed by
additional array hybridization or other experimental approaches. However, the high level of
regulation of those genes does suggest they are regulated, and if accounted for, the number of
genes differentially expressed between the mutant and the parental strain would be
approximately 15% of total genes present on the genome.
Bacterial cells for microarray analysis were taken during log phase (OD 0.5) and higher
Hfq levels were recorded during stationary phase compared to log phase in other bacterial
species[103]. From this, one can infer if levels of Hfq are higher during times of slow growth,
their effects on gene regulation would be more prominent as well. Therefore, if analysis of
differential expression during early stationary phase was done in addition to log phase we could
compare the two levels of PG0228 and overall changes in regulation gaining a better insight
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into PG0228’s overall role. Such studies were not possible for the current time frame but are
planned for the future.
According to the transcriptional profile, the transcription of the downstream gene from
PG0228, nusA, was not altered, indicating the observed changes in mRNA levels were from
global regulation of PG0228 and not due to polar effect of the mutation which would lead to
altered function of nusA (see Table 4). If PG0228 and PG0229 (nusA) were co-transcribed, some
of the changes observed in regulation could have been due to abrogation of the nusA
transcription, however our results show that this was not the case and thus the changes in
transcriptional profile we see are due to deletion of PG0228.
As previously stated, Hfq is considered to act as a key global regulator of gene
expression and facilitate sRNA regulation on target mRNA[56;83]. This therefore, creates a
cascade of gene regulation from changes in Hfq which affects sRNA which affects target mRNA.
Small RNAs can downregulate target protein levels[106] and positively affect ribosomal binding
to mRNA targets causing translation [35;54;101]. Furthermore, sRNAs can regulate one or
multiple target genes while simultaneously being regulated by Hfq or transcription factors
[54;65;97] further complicating regulation. Many sRNAs are trans-encoded, and thus, are not
physically linked to their target mRNAs on the genome. In addition, most of these transencoded sRNAs require Hfq for optimum function[98]. It is likely the changes in transcript
levels of the hypothetical proteins and others are due to inefficient trans-encoded sRNA
function because PG0228’s lack of facilitation.
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It is also important to recall, Hfq can act alone to regulate gene expression by
influencing polyadenylation or translation of mRNA[98]. This demonstrates Hfq’s direct gene
regulation and therefore some genes regulated in Δ0228 could be attributed to PG0228’s direct
regulation.
sRNAs play a key role in regulating their mRNA targets by influencing translation or
mRNA stability. These sRNAs may be involved in numerous cellular processes including cell
development, growth, differentiation, and death by turning genes on and off[1;16;46]. Of the
79 regulated genes found from microarray analysis, 31 were hypothetical proteins, and as a
result, it is impossible to know their function at this time.
Among genes encoding protein of known functions were haemin-uptake encoding genes
(hmuYR). P. gingivalis requires haemin for growth and as a major source of iron. High levels of
haemin are found within humans, though it is bound to proteins and not freely available[52].
Gram-negative pathogenic bacteria, including P. gingivalis, have developed mechanisms for
scavenging iron from haemin bound to proteins within their host[34]. Several studies show the
heamin-uptake mechanisms are organized into operons inside P. gingivalis ensuring these
genes are regulated by one regulator[52;84]. Two P. gingivalis genes detected to be
downregulated (over 7-fold) in the Δ0228 strain include PG1551 (encoding HmuY) and PG1552
(encoding HmuR). Both of these proteins are involved in haemin-uptake and are cotranscribed. The genomic locus transcribing hmuY and hmuR contains six genes (hmuYRSTUV),
each most likely encoding proteins involved in sequestering haemin[52;107]. Downstream
products of the operon, hmuSTUV, are labeled PG1553 thru PG1556. Due to the fact PG1554
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(hmuT) is encoded downstream of hmuYR and these six genes are located on an operon, it is
assumed the transcripts hmuS is also downregulated in the Δ0228 strain.
In times when iron is abundant, HmuY and HmuR are repressed, and when iron levels
are low (as in dental plaque), the level of HmuY is high[70]. Consequently, the expression of
these proteins must be regulated. PG1237, the LuxR family transcriptional regulator, was found
to be required for the expression of hmuY and hmuR [107] and studies show PG0498, LuxS, also
controls the expression of genes involved in haemin uptake[19;45]. However, no changes in
transcription were found in luxR or luxS according to our microarray analysis (see Table 5 and
6). Both the Δ0228 and W83 were grown in the same conditions (see section 2.8.) so the low
levels of hmuY and hmuR found in Δ0228 strain could not be attributed an abundance of iron.
These data would indicate the regulation of these haemin sequestering proteins is more
complex and involves more players other than LuxR and LuxS. We have shown transcript levels
of hmuYRST are lower in the Δ0228 strain however, this is not due to a downregulation of luxR
or luxS, thus the change is from a lack of PG0228, not from altered levels of luxR or luxS. This
suggests PG0228 plays a role in the regulation of haemin-uptake mechanisms.
Another gene upregulated in our study in the PG0228 deficient mutant encodes
rubrerythrin. Rubrerythrin is a non-haem iron protein involved in the protection from reactive
oxygen species (ROS) and oxidative stress[53;87]. The protein is upregulated in several
anaerobic bacteria, including P. gingivalis, during oxidative stress[67;74;92]. It is suggested
rubrerythrin acts as a catalyst reducing intracellular hydrogen peroxide levels[92]. Interestingly,
our data showed rubrerythrin (PG0195) to be upregulated in the Δ0228 strain. Microarray
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analysis also showed upregulation of loci PG1421 and PG1813, both of which encode
ferredoxins. Ferredoxins are a group of small iron-sulfur proteins involved in electron
transfer[23]. Enzymes catalyze the exchange of electrons between electron carriers such as
ferredoxins therefore serving as antioxidants during oxidative stress. The transcrpt level of one
such enzyme, encoded by PG0548, part of the ferredoxin oxidoreductase family, was also
upregulated in the Δ0228 strain. In addition, a previous study subjecting P. gingivalis to 6%
oxygen also showed downregulation of the hmu locus [51] like we have seen for Δ0228. These
indicate genes encoding proteins that play a role in protection from oxidative stress were
upregulated. A bacterium’s resistance to oxidative stress is affected by Hfq but its mechanism
is still not understood[88].

Mutants deficient in hfq show increased oxidation of carbon

levels, lowered tolerance to reactive nitrogen species (RNS), and reactive oxygen species
(ROS)([88;97]. The upregulation of rubrerythrin, ferredoxins, and ferredoxin oxidorecuctase
indicates that the Δ0228 strain has deregulated oxidative stress mechanisms and further work
is required to examine the role of the deregulation in growth of the bacterium with oxidative
stress.
4.3.

RNA Binding to PG0228
Genes, like those involved in haemin-uptake and oxidative stress, need to be quickly

turned on and off to ensure the bacterium’s survival. Small RNAs regulate stress responses,
virulence, metabolism, and many other complex pathways[44;49;86]. However, little is known
about these sRNAs in P. gingivalis, particularly which targets they regulate. It is suggested that
less energy is expelled by the cell using sRNAs compared to synthesizing bulky regulatory
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proteins in response to environmental stress[4]. Because these RNAs are small and
untranslated, they are more cost effective thus allowing a fast response to external stimuli and
fast recovery once the external stimulus is removed[82]. Most of these sRNAs require Hfq for
optimum function, which is Hfq’s most prominent function[86]. We have shown PG0228 is
involved in gene regulation and has numerous similarities to Hfq. However, sRNAs are posttranscriptional regulators, thus information as regards changes in transcripts levels resulting
from destabilization of the mRNA can be found by microarray analysis. Further work is required
to examine the changes in P0228-deficient strain at protein level.
Hfq is a RNA chaperone, therefore, is often found bound to RNA. If it can be shown PG0228
also binds to RNA, it will strengthen the idea PG0228 is most likely an Hfq homologue.
Furthermore, if the identity of these bound RNAs turns out to be known regulatory sRNAs
found in P. gingivalis, it will further strengthen PG0228’s Hfq candidacy. The protein needs to
be crosslinked in vivo to any bound RNA and immunoprecipitated out. However, there is no
known specific antibody to precipitate PG0228. Therefore, a new approach was needed. A
tagged fusion protein approach was therefore used using basic concepts based on the ChIP
assay (Promega). This added a 3’ tag at the genomic level and would be expressed along with
the protein. A specific resin from the company allows our specific tagged protein to be
retrieved in vivo to study bound RNA. For the purpose of this study, the 0228-tagged fusion
mutant was generated which included the 3’ HaLoTag for the bound RNA study.
A reversible cross-linking combined with immunoprecipitation was done with the 0228HaLo strain to study RNA-protein interactions in vivo. Cross-linking with formaldehyde allows
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rapid preservation of interactions between the PG0228 protein and RNA. The cells are then
lysed. A resin based ligand, the HaloLink Resin, covalently interacts with the 0228-tagged
protein and is precipitated out. The cross-links are reversed using glycine and the RNA bound
to the protein is isolated. A RNA library are then created and sent in for sequencing. We have
not yet received the data from this study and therefore it is not yet included at this time.
4.4.

Evaluation of Phenotypic Changes in Δ0228
As stated, no Hfq homologue has been identified in Porphyromonas gingivalis.

However, it is highly likely P. gingivalis possesses an Hfq homologue due to the fact it has been
encoded by nearly half of eubacteria, including pathogens and due to Hfq’s importance as an
overall RNA cofactor[18]. A deficiency in Hfq greatly impacts overall bacterial virulence and
fitness. Luckily, several phenotypic studies can be done since deficient strains are still generally
viable[18]. First deleted in E. coli, the hfq null mutant shows pleiotropic phenotypes, including
decreased yields, increased cell size, osmosensitivity, and increased sensitivity of UV
light[36;88;97].
Growth defects in broth or on plates are generally mild and include longer lag phase
and overall lower final density in B. abortus, E. coli, Francisella tularensis, Legionella
pneumophila, Neisseria meningitides, and Pseudomonas aeruginosa to name a
few[18;25;57;58;75;80;85]. Although, there were no obvious growth defects found in Grampositive bacteria, Listeria monocytogenes or Staphylococcus aureus [18]. As a result, a growth
study was done on Δ0228 strain to view PG0228’s effect on W83 growth.
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Figure 22 is an observation of the mutant growth rate compared to W83. The final
density of both strains is also compared after the 24hr incubation period. The growth study was
repeated with data measured in 2hr and 5hr increments. The data from both studies mirror
data points given in this study with 4hr increments and therefore were not included.
According to the results of the growth study done on Δ0228, the growth rate is
comparable to W83 for the first 8-10 incubation hours during log phase. The mutant bacteria,
however, enters stationary phase, indicated by the loss of slope on the graph, at an earlier time
point than W83. These results match the data found in many hfq null mutants, again
strengthening the idea that PG0228 is potentially an Hfq orthologue.
The environmental niche of P. gingivalis is within a biofilm consisting of several bacterial
species and experiences changes including available nutrients, pH levels, temperature, and
osmolarity [29;38]. In addition, virulent pathogens like P. gingivalis can invade and colonize
within gingival epithelial cells [10;47] but virulence phenotypes of hfq mutants are highly
noticeable in Gram-negative pathogens B. abortus, Salmonella, and V. cholerae, showing high
attenuation in mouse infections[18]. For these reasons, a survival study was done to analyze
the mutant’s ability to handle instant changes in environment. This was done because hfq
mutants often are not able to adjust to changes in their environment (as stated above) with an
exception of S. aureus hfq mutants[12]. The bacteria were exposed to host cell environment to
mimic conditions they encounter in the oral cavity and sub-gingival regions. Our results show
there are no changes in invasion rates between the two strains of bacteria (data not shown),
thus, the number of invading Δ0228 and W83 bacteria is assumed identical. To reduce the

98

number of potential variables, only the host invading bacteria are analyzed by removing
attached and non-invading bacteria. This is done by treating the HN4 cells with antibiotic. As
expected, the Δ0228 strain was not able to handle the added stresses it encountered including
increased oxidation levels, changes in iron availability, and changes in acid levels. This is
evidenced by the significantly lower number of colonies after the incubation period following
the host invasion (Table 8). This result again reiterates the fact that, much like Hfq, PG0228 is
instrumental during high stress conditions, including host invasion, when genes need to be
turned on and off quickly in order for the bacterium to survive.
There are multiple other studies to be done such as the above-mentioned oxidative
stress survival test or other tests that can be predicted based on the changes in transcriptional
profile. Another guide will be results of differentially abundant proteins when comparing the
parental and PG0228 mutant strains. Such studies are planned for the future.
4.5.

Alternate Hypothesis

Although we hypothesize that PG0228 functions like Hfq, PG0228 does also have some
sequence homology with the ribosome maturation factor, RimP. The in vivo maturation of the
50s and 30s ribosomal subunits requires auxiliary proteins that are not part of the mature
ribosomes [69]. Originally found in E. coli, the RimP protein (formerly YhbC or P15a) is essential
for the maturation of the 30S ribosomal subunit. Coincidently, both PG0228 and rimP loci are
found upstream from nusA. However, rimP is co-transcribed with nusA and infB in E. coli[69].
According to our microarray results, there was no gene regulation of the downstream nusA in
the Δ0228 strain. This indicates PG0228 is not co-transcribed with its downstream nusA in
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W83, and therefore it is unlikely PG0228 is rimP. However, PG0228 characteristics are similar
to both Hfq and RimP. It is not impossible PG0228 has both functions since both are
structurally similar and bind RNA. Future studies are needed to determine the effect of PG0228
on ribosome maturation in P. gingivalis.
4.6.

Future Studies
Mutants depleted of hfq have shown regulation in 5-20% of total genes present on the

genome depending on the bacterial species [61]. Δ0228 presents high regulation in 15% of
genes present on the W83 genome. PG0228 and hfq deficient strains are both viable, present a
shorter log phase, and have lower final cell density (excluding Listeria monocytogenes and
Staphylococcus aureus). Furthermore, strains deficient in PG0228 and hfq are less likely to
adapt to changes in host environment. Without the global regulator, genes are less efficiently
turned on or off, resulting in slow bacterial reaction. This gives the host a better chance to rid
themselves of the pathogen. Immunoprecipitation studies show the identities of Hfq-bound
RNAs. We hypothesize the results of our completed immunoprecipitation will also show bound
RNA.
In addition to the RNA sequencing results from the immunoprecipitation, data for
protein analysis and transcriptomic mRNA are still being processed and have not been
returned. We believe this information will shine a bright light on gene regulation by PG0228 at
both the transcription and post-transcription level.
Although we believe PG0228 is an Hfq homologue, several additional studies need to be
completed. An analysis of differential expression during early stationary phase should be
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completed to compare the two levels of PG0228 and overall changes in regulation. The survival
study also needs to be repeated to give better insight into host defense. Plus, more phenotypic
changes need to be measured to compare to other Hfq mutants. However, studies thus far
have demonstrated PG0228 is an excellent Hfq candidate, and we hypothesize further studies
will show PG0228 is an Hfq homologue. Finally, additional work involving determination of the
role of PG0228 in ribosome maturation will shed light on its possible dual role in both
processes. It is possible that both functions are merged in one protein in P. gingivalis which
contains a much smaller genome and associated with that coding capacity compared with E.
coli that can allow itself to code for two proteins.
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